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Abstract. Diastereoselective ring-closing metathesis reactions on chiral trienic perhydro-1,3-benzoxazines 
derived from (-)-8-aminomenthol featuring two diastereotopic olefin chains is described. The 
diastereochemical outcome of the cyclization appeared to be dependent on the length and position of the 
olefin chains in perhydro-1,3-benzoxazine, the degree of substitution of the double bonds and the ruthenium 
catalyst used. After separation of the diastereomers, and removal of the chiral auxiliary, enantiopure oxygen- 
and nitrogen-containing heterocycles were obtained. 
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1 Introduction 
Partially unsaturated oxygen and nitrogen-containing 
heterocycles are common subunits displayed in a 
broad array of interesting and useful biologically 
active molecules as well as natural products.
[1]
 
Among a large number of synthetic approaches, the 
ring-closing metathesis (RCM) reaction has emerged 
as one of the most efficient ways to prepare different-
sized heterocycles.
[2-4]
 A wide range of 
enantioenriched heterocycles can be accessed by 
asymmetric ring-closing metathesis (ARCM), 
asymmetric ring-opening/cross-metathesis (AROCM) 
or asymmetric ring rearrangements (ARR) starting 
from racemic or pro-chiral compounds in the 
presence of chiral well-defined molybdenum- and 
ruthenium-based metathesis catalysts.
[5]
 Despite 
progress in chiral catalyst design, however, a 
significant challenge remains, ARCM of unhindered 
trienes has so far been unsuccessful, resulting in 
extremely low enantioselectivities.
[6]
 In these cases, 
the diastereoselective ring-closing metathesis reaction 
(DSRCM)
[7]
 in substrates in which an existing chiral 
centre controls the direction of cyclization could 
compete advantageously over an enantioselective 
RCM reaction using chiral alkylidene complexes. 
Under certain reaction conditions the DSRCM 
cyclization may be reversible and the observed 
diastereomer ratios reflect a thermodynamic 
preference.
[8]
 If one of the diastereomers is 
energetically much more favoured good 
diastereoselectivities can be achieved not only under 
kinetic control, but also under thermodynamic 
control.
[9]
 On the other hand, the diastereomers could 
be easily separated by chromatography and the 
desired product can be obtained optically pure.
[10]
 
Over the last few years, we have shown that chiral 
perhydro-1,3-benzoxazines derived from (-)-8-
aminomenthol constitute useful chiral auxiliaries in 
different diastereoselective cycloaddition and 
cyclization processes.
[11]
 We now report on the 
synthesis of enantiopure cyclic ethers and amines by 
DSRCM reaction on trienic perhydro-1,3-
benzoxazines with two diastereotopic olefinic groups 
derived from (-)-8-aminomenthol acting as chiral 
template.
[12]
 Scheme 1 summarizes our intentions. In 
general, performing DSRCM metathesis reactions 
with high diastereoselectivity requires that the olefins 
at the prochiral centre do not react with each other 
and also that the primary attack of the catalyst occurs 
at the double bond of the other olefin.
[7a]
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Scheme 1. Retrosynthetic approach to chiral oxygen and 
nitrogen-containing heterocycles. 
Results and Discussion 
 
Synthesis of chiral cyclic ethers  
The starting trienic perhydro-1,3-benzoxazines 4a-j 
were prepared as single diastereomers in good 
chemical yields from (-)-8-(benzylamino)menthol 
1,
[13]
 in three steps, as summarized in Scheme 2. 
Condensation of the amino alcohol 1 with ethyl 
glyoxylate in toluene at reflux furnished a mixture of 
equatorial 2a and axial 2b esters in 85:15 ratio which 
could be separated by silica column chromatography. 
However, 2b is quite configurationally unstable and 
quickly reverts to 2a.
[14]
 Treatment of either 2a or the 
epimeric mixture of 2a and 2b with vinylic or allylic 
Grignard reagents gave the same equatorial carbinols 
3a-d that were converted into the final 
perhydrobenzoxazines 4a-g by allylation the 
hydroxyl group. 
Initial experiments were conducted on perhydro-
1,3-benzoxazine 4a with monosubstituted olefinic 
appendages. Reactions were carried out in CH2Cl2 at 
room temperature. In the presence of a 4 mol% of the 
first-generation Grubbs’ catalyst 5, 4a was converted 
in a mixture of dihydrofurans 7a and 8a in good yield 
and moderate diastereoselectivity (entry 1 in Table 1). 
Employment of the Grubbs’ second generation 
catalyst 6 resulted in a reverse stereoinduction,
[15]
 but 
the stereoselectivity remained moderate (entry 2 in 
Table 1). 
Although it is conceivable that the difference in the 
product ratios of the cyclization in the presence of 5  
 
Scheme 2. Synthesis of perhydrobenzoxazines 4a-g. 
or 6 reflect a kinetic or thermodynamic preference, it 
is quite unlikely that the reaction of 4a with the most 
active ruthenium(II)−N-heterocyclic carbene complex 
6 will take under thermodynamic rather than kinetic 
control in the tested reaction conditions for several 
reasons: (i) the product ratios do not change with 
time; for example, the reaction of 4a in the presence 
of 6 for 30 h led to 7a (35%) and 8a (65%), almost 
the same ratio of diastereomers as after 55 h (entry 
3); (ii) running the reaction in CH2Cl2 at 40 ºC or in 
toluene at 110 ºC for 30 h resulted in partial 
degradation of the material without any significant 
change in the diastereoselectivity (entries 4 and 5); 
(iii) once isolated, diastereomers 7a and 8a do not 
interconvert when subjected to the reaction 
conditions even in ethylene atmosphere. We believe 
that this catalyst-specificity is attributed to the 
different spatial arrangements of the respective 
ligands during the cyclization. 
In a similar way triene 4e with monosubstituted 
olefinic appendages provided dihydropyran 7e as 
major isomer in the presence of 5 and dihydropyran 
8e in the presence of 6 (entries 11 and 12). When the 
first-generation Grubbs’ catalyst 5 was used, the 
cyclopentene resulting from RCM reaction of the 
diastereotopic olefin chains was also isolated in a 
20% yield. This compound was also formed initially 
when the second-generation Grubbs’ catalyst 6 was 
used but over time it was transformed in a mixture of 
7e and 8e by a rearrangement involving a 
diastereoselective ring-opening metathesis reaction. 
As with 4a, a detailed monitoring of the reaction of 
4e in the presence of 6 showed that proportion of 
diastereoisomers 7e and 8e do not change with 
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Table 1. DSRCM reaction of trienes 4a-g.  
 
Entry 4 n R
1 
R
2 
T. (ºC) Catalyst (mol)
[a] 
t (h)
[a] 
Yield (%)
[b] 
dr (%)
[c]
  
1 4a 0 H H 20 5 (2 + 2) 15 + 10 89 7a (64)/8a (36) 
2 4a 0 H H 20 6 (2 + 2) 15 + 15 79 7a (35)/8a (65) 
3 4a 0 H H 20 6 (2 + 2 + 2) 15 + 15 + 25 56 7a (33)/8a (67) 
4 4a 0 H H 40 6 (2 + 2) 15 + 15 68 7a (33)/8a (67) 
5 4a 0 H H 110
[d]
 6 (2 + 2) 15 + 15 55 7a (32)/8a (68) 
6 4b 0 H Me 40 5 (2 + 2) 15 + 10 --- 
[e]
 --- 
7 4b 0 H Me 40 6 (2 + 2) 15 + 15 30
 [e]
 7b (47)/8b (53) 
8 4c 0 Me H 40 5 (2 + 2) 15 + 15 53 
[e]
 7c (>98)
[f]
 
9 4c 0 Me H 20 6 (2) 12 92 7c (>98)
[f]
 
10 4d 0 Me Me 40 6 (2 + 2+ 2) 15 + 15 +10 86 7d (83)/8d (17) 
11 4e 1 H H 20 5 (2) 15 75 7e (77)/8e (23) 
12 4e 1 H H 20 6 (2) 15 96 7e (36)/8e (64) 
13 4f 1 Me H 20 5 (2) 12 94 7f (78)/8f (22) 
14 4f 1 Me H 20 6 (2) 12 93 7f (36)/8f (64) 
15 4g 1 Me Me 40 6 (2 + 2 +2) 15 +15 +10 84 7g (72)/8g (28) 
[a]
 Catalyst was replenished after the time indicated in the Table; see also Experimental Section. 
[b]
 Yield refers to pure 
compounds after column chromatography. 
[c]
 Determined by 
1
H NMR on the reaction mixtures. 
[d]
 Toluene was used as 
solvent. 
[e]
 Different amounts of the starting materials were recovered. 
[f]
 Only one diastereomer was detected by 
1
H NMR 
spectra of the reaction mixture. 
reaction time. The low diastereoselectivity observed 
in the cyclization of 4a and 4e is presumably due to 
competing initiation at the various olefinic sites. 
The effect of olefin substitution on 
stereoselectivity was studied in trienes 4b-d and 4f-g 
(entries 6-10 and 13-15). Triene 4b with two 
diastereotopic vinyl chains and a 1,1-disubstituted 
olefinic chain cyclized with difficulty only in the 
presence of the most active catalyst 6 and with almost 
no diastereoselectivity (entries 6-7). On the contrary, 
the reaction of DRCM occurred with greater 
diastereoselectivity and better chemical yields when 
the two diastereotopic olefinic chains are 1,1-
disubstituted at the double bond. Even dihydrofurans 
and dihydropyrans with a tetrasubstituted double 
bond can be prepared with good chemical yield in the 
presence of 6 (entries 10 and 15). The best result in 
terms of diastereoselectivity was obtained in the 
cyclization of 4c which gave rise to the formation of 
a single diastereomer 7c, in the presence of both 5 
and 6 (entries 8 and 9). 
The diastereomers formed in each reaction were 
isolated and purified by flash chromatography and the 
absolute configuration of the newly created 
stereocentres in 7c, 8d, 8e and 8g was established by 
X-ray diffraction studies.
[16]
 On the other hand, the 
absolute configuration of the newly created 
stereocentre in 7f was determined by its conversion 
into the perhydro-1,3-benzoxazine 9 by 
hydrogenation of the double bonds and 
hydrogenolysis of the benzyl group (Scheme 3), and 
X-ray diffraction analysis.
[16]
 In the same way 
hydrogenation of 7a led to perhydro-1,3-benzoxazine 
10. Unfortunately, 10 turned out to be an oil that does 
not crystallize. However, 10 can be synthesized by 
another way that allows to determine without 
ambiguity its absolute stereochemistry (Scheme 3). 
The treatment of the ketone 11
[14]
 with 
vinylmagnesium chloride provided the alcohol 12. 
The absolute configuration in the newly created 
stereocentre was assigned as R in agreement with 
Eliel’s reports.[13,14] O-Allylation of alcohol 12 
followed of RCM reaction and hydrogenation led to 
10. 
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Scheme 3. Transformation of 7f and 7a into 9 and 10 
and synthesis of 10 from 11 
 
The utility of these DSRCM reactions was 
demonstrated by the transformation of some products 
into the final enantiopure dihydrofurans 15a, 15c and 
15d and dihydropyrans 15e-g which was achieved in 
moderate chemical yield as depicted in Scheme 4 by 
hydrolysis of the N,O-acetal moiety by treatment 
with dilute (~2%) aqueous alcoholic hydrochloric 
acid
[13]
 followed by reduction of the resulting 
aldehyde with sodium borohydride.  
 
Synthesis of chiral cyclic amines 
The starting trienic perhydro-1,3-benzoxazines 19a-e, 
20a-e, and 21a-e were prepared in good to excellent 
yields, as summarized in Scheme 5. Addition of 
vinylic or allylic Grignard reagents to 
perhydrobenzoxazine 16
[12]
 led to the alcohols 19a-c.  
Condensation of the amino alcohol 17
[17]
 with ethyl 
glyoxylate in toluene at reflux furnished a mixture of 
equatorial 18a and axial 18b esters in 76:24 ratio. 
Treatment of either 18a or the epimer 18b with 
vinylic or allylic Grignard reagents gave the same 
equatorial carbinols 19d-e. 
Since protection of the hydroxyl group could be 
important to achieve optimal chemical yield and 
diastereoselectivity in the DSRCM reaction of 
hydroxyl-containing trienic substrates,
[18]
 a set of  
Scheme 4. Transformation of 7a,7c-g into dihydrofurans 
15a,15c-d and dihydropyrans 15e-g. 
substituted metathesis precursors was obtained from 
19a-e introducing two hydroxyl protecting groups of 
different steric demand. The treatment of alcohols 
19a-e with NaH and MeI in refluxing THF led the 
corresponding methyl ethers 20a-e with excellent 
chemical yield. On the other hand, conversion of the 
same alcohols into the corresponding TBDMS ethers 
21a-e can be easily performed by reaction with tert-
butyldimethylsilyl trifluoromethanesulfonate in the 
presence of 2,6-lutidine in dichloromethane at room 
temperature. 
With the trienic substrates 19a-e, 20a-e and 21a-e 
in hand, we next examined the DSRCM reaction 
using the Grubbs’ ruthenium carbene complex 5 and 
6 as catalyst in CH2Cl2 as solvent. The results are 
summarized in Table 2. 
First, the DSRCM reaction of trienic alcohol 19a, 
with monosubstituted olefinic appendages, in the 
presence of 5 was examined but, low conversion to 
cyclic products 22a and 23a and moderate 
diastereoselectivity was observed (entry 1 in Table 2). 
In the presence of the most active ruthenium carbene 
6 a reversal of the stereoinduction occurred but the 
conversion and stereoselectivity remained moderate 
(entry 2). 
The low conversion to cyclic products, even in the 
presence of high amounts of catalyst, could be due to 
coordination of the nitrogen atom of the perhydro-
1,3-benzoxazine to the ruthenium catalyst, resulting 
in deactivation of the metal complex through 
heteroatom–metal chelation.[19] To avoid the 
formation of unreactive chelates we tested the 
protonation of perhydrobenzoxazine 19a.
[20]
 However, 
treatment of the hydrochloride salt of 19a with 4 mol-
% of Grubbs’ catalyst 5, followed by a basic workup, 
gave the desired cyclic products 22a and 23a with 
only a slight improvement in the conversion and 
unfortunately, as an almost equal mixture of 
diastereomers (entry 3). To our delight, the ruthenium 
carbenes 5 and 6 promoted efficient ring closure of 
the methyl ether 20a and the silyl ether 21a (entries 
4-7). The best results in terms of diastereoselectivity 
were achieved with the bulkier tert-butyldimethylsilyl 
protecting group. In the presence of the Grubbs’ 
ruthenium carbene complex 6 perhydrobenzoxazine 
21a led to 26a and 27a in a ratio of 13:87 (entry 7). 
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Scheme 5. Synthesis of perhydrobenzoxazines 19a-e, 20a-
e and 21a-e. 
Neither the trienic alcohol 19b nor the 
corresponding silyl ether 21b with two 1,1-
disubstituted diastereotopic olefinic chains cyclized 
to the tetrahydropyridine ring (entries 8 and 11). The 
referable methyl ether 20b failed also to cyclize if the 
catalyst used is 5 (entry 9), however, in the presence 
of 6, cyclized easily to a mixture of diastereomeric 
tetrahydropyridines 24b and 25b with a trisubstituted 
double bond with good diastereoselectivity (92:8, 
entry 10). 
Similarly, tetrahydro-1H-azepines can be prepared 
by DSRCM reaction of trienes 19c, 20c, 21c, 20d and 
21d (entries 12-22). Again, the best results in terms 
of stereoselectivity were achieved when the hydroxyl 
group was protected as methyl ether if the 
diastereotopic olefin chains are 1,1-disubstituted 
entries 14 and 15) or as tert-butyldimethylsilyl ether 
if the diastereotopic olefin chains are 
monosubstituted (entries 21 and 22). In both cases, 
only the formation of a single diastereomer was 
detected by 
1
H NMR spectra of the reaction mixture. 
More interesting, the ruthenium carbene 6 
catalyzed the DSRCM reaction of substrates 19e, 20e 
and 21e providing the eight-membered cyclic amines 
(entries 23-25). As in 19c, the OH group in 19e does 
not seem to play a detrimental role in the 
diastereoselectivity (entry 23). Starting from the 
methyl ether 20e, the corresponding 
hexahydroazocine 24e with a trisubstituted double 
bond was obtained with good chemical yield and an 
excellent diastereoselectivity of 97: 3 (entry 24).  
 
After isolation and purification by flash 
chromatography of the diastereomers formed in each 
reaction, the absolute configuration of the newly 
created stereocenters in 25a, 24c and 27d was 
established by X-ray diffraction studies.
[16]
 The 
absolute configuration of the newly created 
stereocenters in 24e was determined by its conversion 
into the aminomenthol derivatives 28 by nucleophilic 
ring opening of the N,O-acetal moiety by aluminum 
hydride (Scheme 6) and X-ray diffraction analysis.
[16]
 
On the other hand, the NOESY spectra of 24b 
showed a cross signal for the hydrogen attached to 
the N,O-acetallic carbon of the oxazine ring and the 
hydrogens of the methoxy group indicating their cis 
relationship and that, therefore, the absolute 
configuration of the new stereocenter created at the 
DSRCM reaction is R.  
On the other hand, O-methylation of 23a provided 
25a, while the tert-butyldimethylsilyl ether cleavage 
of an inseparable mixture of 26a and 27a (13:87) 
with tetrabutylammonium fluoride in THF
[21]
 
furnished a mixture of 22a and 23a in a 15:85 ratio, 
which allowed the assignation of the absolute 
stereochemistry of 25a, 27a and their epimers 24a 
and 26a respectively. In a similar way, the absolute 
configuration of the other RCM reaction products of 
Table 2 was assigned. Methylation of 22c provided 
24c, while deprotection of tert-butyldimethylsilyl 
ether in 27c furnished alcohol 23c. Deprotection of 
silyl ether in 27d followed by methylation of the 
resulting alcohol led 25d. Last, methylation of 22e 
provided 24e, while the tert-butyldimethylsilyl ether 
cleavage of an inseparable mixture of 26e and 27e in 
a 45:55 ratio furnished a mixture of the epimeric 
azocines 22e and 23e in 41:59 ratio.  
Transformation of compounds 25a, 24b, 22c, 24c, 
25d and 24e into the final enantiopure 
tetrahydropyridines 29 and 33, the tetrahydro-1H-
azepines 30, 32 and 34 and the hexahydroazocine 32 
was performed in three steps,
[22]
 as depicted in 
Scheme 7. The reductive ring- opening of the N,O-
acetal moiety by treatment with aluminium hydride 
generated in situ from lithium aluminium hydride and 
aluminium chloride, in THF at room temperature led 
to amino menthol derivatives in good to excellent 
yields. For a complete reduction of 24b was
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Table 2. DSRCM reaction of trienes 21-23. 
 
Entry  m n R
1 
R
2 
T (ºC) Catalyst 
(mol)
[a] 
t (h)
[a] 
Yield 
(%)
[b] 
dr (%)
[c]
  
1 19a 1 0 H H 40 5 (2 + 2 +2 + 2) 15 + 15 + 15 + 10 27
[d]
 22a (64)/23a (36) 
2 19a 1 0 H H 40 6 (2 + 2 +2) 15 + 15 + 10 38
[d]
 22a (35)/23a (65) 
3 19a·HCl 1 0 H H 20 5 (2 + 2) 15 + 50  45
[d]
 22a (48)/23a (52) 
4 20a 1 0 H Me 20 5 (2 + 2) 15 + 15 90 24a (67)/25a (33) 
5 20a 1 0 H Me 20 6 (2 + 2) 15 + 10 85 24a (27)/25a (73) 
6 21a 1 0 H TBDMS 20 5 (2 + 2) 15 + 15 83 26a (74)/27a (26) 
7 21a 1 0 H TBDMS 20 6 (2 + 2) 15 + 15 88 26a (13)/27a (87) 
8 19b 1 0 Me H 40 6 (2 + 2) 15 + 12 ---
 [d]
 --- 
9 20b 1 0 Me Me 40 5 (2 + 2) 15 + 15 +10 ---
 [d]
 --- 
10 20b 1 0 Me Me 40 6 (2 + 2) 15 + 12 81 24b (92)/25b (8) 
11 21b 1 0 Me TBDMS 40 6 (2 + 2) 15 + 12 ---
 [d]
 --- 
12 19c 1 1 Me H 40 5 (2 + 2 + 2 + 2) 15 + 15 + 15 + 10 78 22c (92)/23c (8) 
13 19c 1 1 Me H 40 6 (2 + 2 +2) 15 +15 +10 78 22c (73)/23c (27) 
14 20c 1 1 Me Me 40 5 (2 + 2) 15 + 10  94 24c (>98)
[e] 
15 20c 1 1 Me Me 40 6 (2) 12  92 24c (>98)
[e] 
16 21c 1 1 Me TBDMS 40 5 (2 + 2) 15 + 10 90 26c (35)/27c (65) 
17 21c 1 1 Me TBDMS 40 6 (2 + 2) 15 + 10 92 26c (12)/27c (88) 
18 19d 2 0 H H 20 6 (2 + 2) 15 + 10 ---
 [d]
 --- 
19 20d 2 0 H Me 20 5 (2 + 2) 15 + 10 91 24d (45)/25d (55) 
20 20d 2 0 H Me 20 6 (2) 12 85 24d (30)/25d (70) 
21 21d 2 0 H TBDMS 20 5 (2 + 2) 15 + 10 45 27d (>98)
[e] 
22 21d 2 0 H TBDMS 20 6 (2 + 2) 15 + 10 94 27d (>98)
[e] 
23 19e 2 1 Me H 40 6 (2 + 2 + 2) 15 + 15 + 10  52 22e (90)/23e (10) 
24 20e 2 1 Me Me 40 6 (3) 4 90 24e (97)/25e (3) 
25 21e 2 1 Me TBDMS 40 6 (3) 4 91 26e (45)/27e (55) 
[a]
 Catalyst was replenished after the time indicated in the Table; see also Experimental Section. 
[b]
 Yield refers to pure 
compounds after column chromatography. 
[c]
 Determined by 
1
H NMR on the reaction mixtures. 
[d]
 Different amounts of the 
starting materials were recovered.
[e] 
Only one diastereomer was detected by 
1
H NMR spectra of the reaction mixture
necessary to heat to 60 ºC and under these reaction 
conditions demethylation of the tertiary methyl ether 
also occurs. Elimination of the menthol appendage in 
these derivatives was effected by oxidation with PCC 
in CH2Cl2 at room temperature to the corresponding 
8-aminomenthone derivatives followed by β-
elimination by treatment with KOH in H2O–THF–
MeOH (Scheme 7). 
Conclusion 
In summary, the synthetic sequence described above 
constitutes a short and efficient procedure for the 
preparation of a variety of chiral oxygen- and 
nitrogen-containing heterocycles. The 
stereochemistry of the DSRCM reaction products is 
dependent on the length and position of the olefin 
chains in the perhydro-1,3-benzoxazine, the 
substitution pattern of the double bonds and the 
ruthenium carbene complex used as catalyst. The 
results collected in Table 1 and 2 show that the two 
catalysts, 5 and 6, behave differently both in terms of 
efficiency and diastereoselectivities, leading to the 
opposite epimers for the final heterocycle except in 
the case of very high selectivity were reached, where 
the major product obtained with catalyst 6 correspond 
to the one which is mainly produced by catalyst 5  
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Scheme 6. Stereochemical correlation of compound 24e. 
Scheme 7. Transformation of compounds 25a, 24b, 22c, 
24c, 25d and 24e into the final enantiopure 
tetrahydropyridines 29 and 33, the tetrahydro-1H-azepines 
30, 32 and 34, and the hexahydroazocine 32. 
when the diastereoselectivity is moderate. In addition, 
the results seem to show that the substrate plays a 
major role in the selection of the final stereoisomer as 
compared to the catalyst. Although in some cases 
only moderate diastereoselectivities are achieved in 
the cyclization, after separation of the diastereomers 
and removal of the chiral auxiliary enantiopure 
oxygen- and nitrogen-containing heterocycles are 
obtained. 
 
Experimental Section 
General information 
All reactions were carried out in anhydrous solvents, under 
an argon atmosphere, and in oven-dried glassware. 
Commercial reagents were used without purification. 
1
H 
NMR (300 or 400 MHz) and 
13
C NMR (75 or 100 MHz) 
spectra were recorded in CDCl3. Chemical shifts for 
protons are reported in ppm from tetramethylsilane with 
the residual CHCl3 resonance as an internal reference. 
Chemical shifts for carbons are reported in ppm from 
tetramethylsilane and are referenced to the carbon 
resonance of the solvent. Data are reported as follows: 
chemical shift, multiplicity (s = singlet, d = doublet, t = 
triplet, q = quartet, m = multiplet, br = broad), coupling 
constants in hertz, and integration. High resolution mass 
spectrometry (HRMS) analysis was performed using a 
quadrupole spectrometer equipped with a TOF analyzer. 
Specific rotations were measured using a 5 mL cell with a 
1 dm path length and a sodium lamp, and the concentration 
is given in g per 100 mL. Melting points were determined 
in open capillary tubes and are uncorrected. Flash 
chromatography was carried out using silica gel (230–240 
mesh). TLC analysis was performed on glass-backed plates 
coated with silica gel 60 and an F254 indicator, and 
visualized either by UV irradiation or by staining with I2 or 
phosphomolybdic acid solution. Chemical yields refer to 
pure isolated substances. Compounds 1,
[13]
 11,
[14]
 16
[12]
 and 
17
[17]
 have been described previously. Compounds 2b, 26a, 
27a, 25b, 26c, 23e, 26e and 27e could not be isolated and 
obtained pure after flash chromatography. 
General procedure for the synthesis of benzoxazines 2 
and 18. To a solution of 50 mmol of 1 or 17 in 150 mL of 
toluene was added 13 mL of a commercial solution of 
ethyl gyoxalate, 50% in toluene (65 mmol). The solution 
was heated at reflux with a Dean-Stark trap until 
disappearance of the starting material (TLC, 12-24 h). The 
solvent was removed in vacuo and the residue was 
chromatographed on silica gel using hexanes/AcOEt as an 
eluent. 
Ethyl (2S,4aS,7R,8aR)-3-benzyl-4,4,7-
trimethyloctahydro-2H-benzo[e][1,3]oxazine-2-
carboxylate (2a). This compound was obtained from 1 
(25.0 g) and purified by flash chromatography 
(hexanes/ethyl acetate 15:1) to give 20.37 g of 2a and 9.33 
g of a mixture of diastereomers 2a and 2b (90% yield). 2b 
was quite configurationally unstable and quickly reverts to 
2a. White solid. Mp 81-82 ºC (from hexane). [α]D
25
 = -51.6 
(c = 0.7 ethyl acetate); 
1
H NMR (400 MHz, CDCl3):  0.93 
(d, J = 6.5 Hz, 3H); 0.94-1.03 (m 2H); 0.98 (t, J = 7.2 Hz, 
3H); 1.03 (s, 3H); 1.24 (m, 1H); 1.28 (s, 3H); 1.46 (m, 
1H); 1.54-1.62 (m, 2H); 1.70 (m, 1H); 1.99 (m, 1H); 3.54 
(td, J1 = 10.5 Hz, J2 = 4.0 Hz, 1H); 3.68 (dq, J1 = 10.8 Hz, 
J2 = 7.2 Hz, 1H); 3.85 (dq, J1 = 10.8 Hz, J2 = 7.2 Hz, 1H); 
3.88 (d, J = 17.4 Hz, 1H); 3.95 (d, J = 17.4 Hz, 1H); 5.19 
(s, 1H); 7.12 (t, J = 7.5 Hz, 1H); 7.22 (t, J = 7.5 Hz, 2H); 
7.36 (d, J = 7.5 Hz, 2H). 
13
C NMR (100 MHz, CDCl3):  
13.7 (CH3); 20.7 (CH3); 22.2 (CH3); 24.9 (CH2); 26.9 
(CH3); 31.4 (CH); 34.9 (CH2); 41.1 (CH2); 45.6 (CH); 48.1 
(CH2); 57.4 (C); 61.0 (CH2); 76.3 (CH); 85.7 (CH); 126.1 
(CH); 127.3 (2 CH); 127.7 (2 CH); 142.2 (C); 168.8 (C). 
IR (Nujol dispersion): 3080, 1750, 1600, 725, 695 cm
-1
. 
HRMS calcd for C21H32NO3 [M + H]
+
 346.2377, found 
346.2373 
Ethyl (2S,4aS,7R,8aR)-3-(but-3-en-1-yl)-4,4,7-
trimethyloctahydro-2H-benzo[e][1,3]oxazine-2-
carboxylate (18a). This compound was obtained from 17 
(12.0 g) and purified by flash chromatography 
(hexanes/ethyl acetate 15:1). Yield: 10.83 g, 66%. 
Colorless oil. [α]D
25
 = -35.7 (c = 1.6 CH2Cl2); 
1
H NMR 
(300 MHz, CDCl3):  0.88 (d, J = 6.5 Hz, 3H); 0.89-0.98 
(m, 2H); 1.11 (m, 1H); 1.16 (s, 6H); 1.28 (t, J = 7.2 Hz, 
3H); 1.35-1.48 (m, 2H); 1.56-1.69 (m, 2H); 1.93 (m, 1H); 
2.08-2.17 (m, 2H); 2.57 (m, 1H); 2.71 (m, 1H); 3.46 (td, J1 
= 10.6 Hz, J2 = 4.0 Hz, 1H); 4.14-4.32 (m, 2H);  4.88-4.98 
(m, 2H); 5.04 (s, 1H); 5.79 (m, 1H). 
13
C NMR (75 MHz, 
CDCl3):  14.1 (CH3); 19.9 (CH3); 22.1 (CH3); 24.9 (CH2); 
26.1 (CH3); 31.2 (CH); 34.8 (CH2); 37.2 (CH2); 40.9 
(CH2); 44.5 (CH2); 45.6 (CH); 57.1 (C); 61.3 (CH2); 76.0 
(CH); 85.7 (CH); 115.3 (CH2); 136.1 (CH); 169.0 (C). IR 
(película): 3075, 1760, 1640, 910 cm
-1
. HRMS calcd for 
C18H32NO3 [M + H]
+
 310.2377, found 310.2373. 
Ethyl (2R,4aS,7R,8aR)-3-(but-3-en-1-yl)-4,4,7-
trimethyloctahydro-2H-benzo[e][1,3]oxazine-2-
carboxylate (18b). This compound was obtained from 17 
(12.0 g) and purified by flash chromatography 
(hexanes/ethyl acetate 15:1). Yield: 3.42 g, 21%. Colorless 
oil. [α]D
25
 = +35.5 (c = 1.4  CH2Cl2); 
1
H NMR (300 MHz, 
CDCl3):  0.88-1.09 (m, 3H); 0.93 (d, J = 6.5 Hz, 3H); 
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1.01 (s, 3H); 1.16 (s, 3H); 1.30 (t, J = 7.1 Hz, 3H); 1.39-
1.60 (m, 2H); 1.63-1.75 (m, 2H); 1.99 (m, 1H); 2.20-2.32 
(m, 2H); 2.88-3.01 (m, 2H); 3.94 (td, J1 = 10.6 Hz, J2 = 4.0 
Hz, 1H); 4.18-4.25 (m, 2H);  4.80 (s, 1H); 4.98-5.09 (m, 
2H); 5.82 (m, 1H).  
13
C NMR (75 MHz, CDCl3):  14.0 
(CH3); 19.7 (CH3); 22.1 (CH3); 24.8 (CH2); 27.5 (CH3); 
31.0 (CH); 34.7 (CH2); 34.8 (CH2); 41.2 (CH2); 46.6 
(CH2); 47.9 (CH); 55.3 (C); 60.7 (CH2); 70.7 (CH); 83.7 
(CH); 115.6 (CH2); 136.3 (CH); 172.6 (C). IR (film): 3075, 
1740, 1640, 910 cm
-1
. HRMS calcd for C18H32NO3 [M + 
H]
+
 310.2377, found 310.2377. 
General procedure for addition of Grignard reagents to 
2a, 11, 16 and the mixture of 18a and 18b. A commercial 
solution of the appropriate vinyl- or allyl-Grignard 
derivative in ether or THF (46 mmol) was slowly added at 
0 
o
C to a solution of the appropriate benzoxazine (20 
mmol) in diethyl ether (70 mL). The mixture was stirred at 
this temperature until disappearance of the starting material 
(TLC, 20-45 min). The reaction mixture was quenched 
with saturated ammonium chloride and the product was 
extracted with diethyl ether (3 x 40 mL). The organic 
extracts were washed with brine, dried over anhydrous 
MgSO4, and the solvent was evaporated in vacuo. The 
residue was chromatographed on silica gel using 
hexanes/AcOEt as an eluent.  
For ketone 11, the addition of vinyl magnesium choride 
(1.2 eq) was carried out at -40 °C and THF was used as 
solvent instead of ether.  
3-((2S,4aS,7R,8aR)-3-benzyl-4,4,7-trimethyloctahydro-
2H-benzo[e][1,3]oxazin-2-yl)penta-1,4-dien-3-ol (3a). 
This compound was obtained from 2a (7.0 g) and purified 
by flash chromatography (hexanes/ethyl acetate 60:1). 
Yield: 5.96 g, 83%. Colorless oil. [α]D
25
 = +1.8 (c = 0.9  
EtOH); 
1
H NMR (300 MHz, CDCl3):  0.89-1.04 (m, 2H); 
0.96 (s, 3H); 0.97(d, J = 6.5 Hz, 3H); 1.16 (m, 1H); 1.32 (s, 
3H); 1.32-1.64 (m, 3H);  1.73 (m, 1H); 1.96 (m, 1H); 2.82 
(s, 1H); 3.57 (dt, J1 = 10.5 Hz, J2 = 4.0 Hz, 1H); 3.85 (d, J 
= 18.5 Hz, 1H); 4.55 (d, J = 18.5 Hz, 1H); 4.72 (s, 1H); 
4.99 (dd, J1 = 10.6 Hz, J2 = 1.6 Hz, 2H); 5.08 (dd, J1 = 
17.3 Hz, J2 = 1.6 Hz, 1H); 5.22 (dd, J1 = 17.3 Hz, J2 = 1.6 
Hz, 1H); 6.02 (ddd, J1 = 17.3 Hz, J2 = 10.6 Hz, J3 = 0.6 Hz, 
1H);  6.12 (dd, J1 = 17.3 Hz, J2 = 10.6 Hz, 1H); 7.16 (m, 
1H); 7.25-7.34 (m, 4H). 
13
C NMR (75 MHz, CDCl3):  
22.2 (CH3); 22.9 (CH3); 24.9 (CH2); 26.6 (CH3); 31.4 
(CH); 35.1 (CH2); 41.3 (CH2); 44.6 (CH); 46.7 (CH2); 58.6 
(C); 76.1 (C); 77.9 (CH); 91.0 (CH); 112.7 (CH2); 113.0 
(CH2); 125.6 (CH); 126.6 (2 CH); 127.9 (2 CH); 139.8 
(CH); 140.2 (CH); 143.7 (C). IR (film): 3535 (broad), 3025, 
1605, 760, 720, 695 cm
-1
. HRMS calcd for C23H34NO2 [M 
+ H]
+
 356.2584, found 356.2586 
3-((2S,4aS,7R,8aR)-3-benzyl-4,4,7-trimethyloctahydro-
2H-benzo[e][1,3]oxazin-2-yl)-2,4-dimethylpenta-1,4-
dien-3-ol (3b). This compound was obtained from 2a (7.0 
g) and purified by flash chromatography (hexanes/ethyl 
acetate 60:1). Yield: 6.22 g, 88%. Colorless oil. [α]D
25
 = 
+22.5 (c = 0.9 CH2Cl2). 
1
H NMR (300 MHz, CDCl3): 
 -1.05 (m, 2H); 0.94 (d, J = 6.5 Hz, 
3H); 1.14 (m, 1H); 1.27 (m, 1H); 1.31 (s, 3H); 1.43-1.59 
(m, 2H);  1.67 (s, 3H); 1.68 (m, 1H); 1.77 (s, 3H); 1.85 (m, 
1H); 3.00 (s, 1H); 3.61 (dt, J1 = 10.6 Hz, J2 = 3.9 Hz, 1H); 
3.78 (d, J = 17.6 Hz, 1H); 4.66 (t, J = 1.5 Hz, 1H); 4.92-
5.01 (m, 4H); 5.23 (s, 1H); 7.11 (m, 1 H); 7.19-7.27 (m, 4 
H). 
13
C NMR (75 MHz, CDCl3):  18.9(CH3); 19.4(CH3); 
22.2 (CH3); 22.5 (CH3); 24.8 (CH2); 27.3 (CH3); 31.4 
(CH); 35.1 (CH2); 41.3 (CH2); 43.3 (CH); 47.5 (CH2); 58.6 
(C); 77.0 (CH); 80.5 (C); 85.2 (CH); 110.8 (CH2); 113.1 
(CH2); 124.9 (CH); 126.6 (2 CH); 127.1 (2 CH); 141.3 (C); 
145.5 (C); 147.6 (C). IR (film): 3550 (broad), 3085, 2868, 
1640, 1605, 750, 720, 695 cm
-1
. HRMS calcd for 
C25H38NO2 [M + H]
+
 384.2897, found 384.2900. 
3-((2S,4aS,7R,8aR)-3-benzyl-4,4,7-trimethyloctahydro-
2H-benzo[e][1,3]oxazin-2-yl)-2,4-dimethylpenta-1,4-
dien-3-ol (3c). This compound was obtained from 2a (3.6 
g) and purified by flash chromatography (hexanes/ethyl 
acetate 60:1). Yield: 3.61 g, 90%. White solid. Mp 82-84 
ºC (from hexane). [α]D
25
 = +62.0 (c = 0.8  CH2Cl2); 
1
H 
NMR (300 MHz, CDCl3):  0.80-0.93 (m, 2H); 0.87 (s, 
3H); 0.94 (d, J = 6.5 Hz, 3H); 1.09 (m, 1H); 1.25 (s, 3H); 
1.52-1.68 (m, 4H);  1.92 (m, 1H); 2.24-2.40 (m, 4H); 2.43 
(s, 1H); 3.51 (td, J1 = 10.4 Hz, J2 = 3.9 Hz, 1H); 3.88 (d, J 
= 18.3 Hz, 1H); 4.50 (s, 1H); 4.96 (d, J = 18.3 Hz, 1H); 
5.02-5.08 (m, 4H); 5.78-6.00 (m, 2H);  7.11 (m, 1H); 7.19-
7.22 (m, 2H); 7.36-7.39 (m, 2H). 
13
C NMR (75 MHz, 
CDCl3):  22.3 (CH3); 22.7 (CH3); 24.9 (CH2); 26.9 (CH3); 
31.5 (CH); 35.2 (CH2); 38.7 (CH2); 41.4 (CH2); 43.6 
(CH2); 43.9 (CH); 47.1 (CH2); 58.4 (C); 75.6 (C); 77.6 
(CH);  88.0 (CH); 118.0 (CH2); 118.1 (CH2); 125.4 (CH); 
126.7 (2 CH); 127.8 (2 CH); 134.0 (CH); 134.2 (CH); 
144.4 (C). IR (Nujol dispersion): 3399 (broad), 3070, 1720, 
1640, 720, 695 650 cm
-1
. HRMS calcd for C25H38NO2 [M 
+ H]
+
 384.2897, found 384.2905. 
4-((2S,4aS,7R,8aR)-3-benzyl-4,4,7-trimethyloctahydro-
2H-benzo[e][1,3]oxazin-2-yl)-2,6-dimethylhepta-1,6-
dien-4-ol (3d). This compound was obtained from a 
mixture of 2a and 2b (7.0 g) and purified by flash 
chromatography (hexanes/ethyl acetate 60:1). Yield: 7.64 g, 
92%. Colorless oil. [α]D
25
 = +14.3 (c = 1.4  CH2Cl2); 
1
H 
NMR (300 MHz, CDCl3): 0.79-0.98 (m, 2H); 0.89(s, 3H); 
0.94 (d, J = 6.5 Hz, 3H); 1.11 (m, 1H); 1.26 (s, 3H); 1.26-
1.67 (m, 4H);  1.68 (s, 3H); 1.77 (s, 3H); 1.85 (m, 1H); 
2.20 (d, J = 14.9 Hz, 1H); 2.22 (d, J = 14.9 Hz, 1H); 2.32 
(d, J = 14.9 Hz, 2H);  2.68 (s, 1H); 3.49 (td, J1 = 10.6 Hz, 
J2 = 4.0 Hz, 1H); 3.91 (d, J = 18.5 Hz, 1H); 4.59 (s, 1H); 
4.66-4.84 (m, 5H); 7.13 (m, 1 H); 7.23-7.32 (m, 2H); 7.39-
7.41 (m, 2H). 
13
C NMR (75 MHz, CDCl3):  22.4(CH3); 
22.8(CH3); 24.7 (CH3); 24.7 (CH3); 24.9 (CH2); 26.9 
(CH3); 31.5 (CH); 35.2 (CH2); 41.3 (CH2); 43.4 (CH2); 
44.0 (CH); 47.2 (CH2); 47.4 (CH2); 58.7 (C); 76.5 (C); 
77.0 (CH);  88.4 (CH); 113.5 (CH2); 114.1 (CH2); 125.5 
(CH); 126.8 (2 CH); 127.9 (2 CH); 143.4 (C); 143.8 (C); 
147.6 (C). IR (film): 3545 (broad), 3070, 2870, 1640, 720, 
695 650 cm
-1
. HRMS calcd for C27H42NO2 [M + H]
+
 
412.3210, found 412.3212. 
(R)-3-((2S,4aS,7R,8aR)-3-benzyl-4,4,7-
trimethyloctahydro-2H-benzo[e][1,3]oxazin-2-yl)pent-
1-en-3-ol (12). This compound was obtained from 11 (2.5 
g) and purified by flash chromatography (hexanes/ethyl 
acetate 50:1). Yield: 2.30 g, 85%. White solid. Mp 118-
119 ºC (from hexane). [α]D
25
 = +8.9 (c = 1.1 CH2Cl2). 
1
H 
NMR (300 MHz, CDCl3):  0.82 (t, J = 7.4 Hz, 3H); 0.88 
(m, 2H); 0.94 (d, J = 6.5 Hz, 3H); 0.96 (s, 3H); 1.14 (m, 
1H); 1.33 (s, 3H); 1.43-1.68 (m, 5H);  1.70 (m, 1H); 1.91 
(m, 1H); 2.50 (s, 1H); 3.53 (td, J1 = 10.5 Hz, J2 = 3.8 Hz, 
1H); 3.83 (d, J = 18.6 Hz, 1H); 4.61 (d, J = 18.6 Hz, 1H); 
4.67 (s, 1H, CH); 4.94 (d, J = 17.1 Hz, 1H); 4.95 (d, J = 
11.1 Hz, 1H); 5.97 (dd, J1 = 17.1 Hz, J2 = 11.1 Hz, 1H); 
7.13 (m, 1H); 7.24-7.32 (m, 4H). 
13
C NMR (75 MHz, 
CDCl3):  7.53 (CH3); 22.3 (CH3); 22.9 (CH3); 24.9 (CH2); 
26.6 (CH3); 31.4 (CH and CH2); 35.1 (CH2); 41.3 (CH2); 
44.6 (CH); 46.8 (CH2); 58.3 (C); 76.0 (C); 78.0 (CH); 90.9 
(CH); 113.1 (CH2); 125.6 (CH); 126.3 (2 CH); 128.1 (2 
CH); 140.8 (CH); 143.9 (C). IR (film): 3540 (broad), 3025, 
1605, 765, 725, 695 cm
-1
. HRMS calcd for C23H36NO2 [M 
+ H]
+
 358.2741, found 358.2746 
3-((2S,4aS,7R,8aR)-3-allyl-4,4,7-trimethyloctahydro-
2H-benzo[e][1,3]oxazin-2-yl)penta-1,4-dien-3-ol (19a). 
This compound was obtained from 16 (10.0 g) and purified 
by flash chromatography (hexanes/ethyl acetate 45:1). 
Yield: 8.70 g, 84%. Colorless oil. [α]D
25
 = -42.8 (c = 1.4 
CH2Cl2).
 1
H NMR (300 MHz, CDCl3):  0.84-0.94 (m, 
2H); 0.92  (d, J = 6.2 Hz, 3H); 1.06 (m, 1H); 1.09 (s, 3H); 
1.21 (s, 3H); 1.43-1.51 (m, 2H);  1.58 (m, 1H); 1.69 (m, 
1H); 1.90 (m, 1H); 2.97 (s, 1H); 3.24 (dd, J1 = 18.3 Hz, J2 
= 4.9 Hz, 1H); 3.47 (td, J1 = 10.6 Hz, J2 = 3.9 Hz, 1H); 
3.79 (dd, J1 = 18.3 Hz J2= 4.9 Hz, 1H ); 4.56 (s, 1H); 4.97-
5.17 (m, 4H); 5.32 (dd, J1 = 12.8 Hz, J2 = 1.7 Hz, 1H); 
5.38 (dd, J1 = 12.8 Hz, J2 = 1.7 Hz, 1H); 5.85 (m, 1H);  
6.00 (dd, J1 = 17.3 Hz, J2 = 10.8 Hz, 1H); 6.15 (dd, J1 = 
17.3 Hz, J2 = 10.8 Hz, 1H).  
13
C NMR (75 MHz, CDCl3):  
22.2 (CH3); 22.8 (CH3); 24.9 (CH2); 26.3 (CH3); 31.4 
(CH); 35.1 (CH2); 41.2 (CH2); 45.0 (CH); 45.3 (CH2); 58.0 
(C); 75.7 (C); 77.9 (CH); 90.7 (CH); 112.5 (2 CH2); 113.5 
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(CH2); 140.1 (CH); 140.6 (CH); 141.4 (CH).  IR (film): 
3524 (broad), 3085, 1640, 820, 720, 635 cm
-1
. HRMS 
calcd for C19H32NO2 [M + H]
+
 306.2428, found 306.243 
3-((2S,4aS,7R,8aR)-3-allyl-4,4,7-trimethyloctahydro-
2H-benzo[e][1,3]oxazin-2-yl)-2,4-dimethylpenta-1,4-
dien-3-ol (19b). This compound was obtained from 16 
(10.0 g) and purified by flash chromatography 
(hexanes/ethyl acetate 45:1). Yield: 9.80 g, 87%. Colorless 
oil. [α]D
25
 = +8.3 (c = 1.0 CH2Cl2).
 1
H NMR (300 MHz, 
CDCl3):  0.90-1.00 (m, 2H); 0.92 (d, J = 6.5 Hz, 3H); 
1.05 (m, 1H); 1.07 (s, 3H); 1.23 (s, 3H); 1.43-1.62 (m, 
3H); 1.69 (s, 6H); 1.71 (m, 1H); 1.88 (m, 1H); 3.02 (s, 
1H); 3.34 (dd, J1 = 17.4 Hz, J2 = 6.4 Hz, 1H); 3.53 (td, J1 = 
10.6 Hz, J2 = 3.9 Hz, 1H); 4.05 (dd, J1 = 17.4 Hz, J2 = 4.3 
Hz, 1H); 4.79-4.98 (m, 5H); 5.06 (s, 1H); 5.21 (m, 1H); 
5.89 (m, 1H). 
13
C NMR (75 MHz, CDCl3):  19.0 (CH3); 
19.1 (CH3); 22.2 (CH3); 22.6 (CH3); 25.0 (CH2); 27.1 
(CH3); 31.4 (CH); 35.2 (CH2); 41.4 (CH2); 44.4 (CH); 46.9 
(CH2); 58.3 (C); 77.0 (CH); 80.3 (C); 85.5 (CH); 110.9 
(CH2); 111.3 (CH2); 112.0 (CH2); 142.8 (CH); 143.5 (CH); 
147.4 (CH). IR (film): 3550 (broad), 3085, 1640, 735, 610 
cm
-1
. HRMS calcd for C21H36NO2 [M + H]
+
 334.2741, 
found 334.2748. 
4-((2S,4aS,7R,8aR)-3-allyl-4,4,7-trimethyloctahydro-
2H-benzo[e][1,3]oxazin-2-yl)-2,6-dimethylhepta-1,6-
dien-4-ol (19c). This compound was obtained from 16 
(10.0 g) and purified by flash chromatography 
(hexanes/ethyl acetate 45:1). Yield: 12.02 g, 98%. 
Colorless oil. [α]D
25
 = -25.3 (c = 1.8 CH2Cl2).
 1
H NMR 
(300 MHz, CDCl3):  0.83-0.94 (m, 2H); 0.92 (d, J = 6.5 
Hz, 3H); 0.99 (m, 1H); 1.07 (s, 3H); 1.17 (s, 3H); 1.43-
1.68 (m, 3H);  1.70-1.70-1.76 (m, 2H); 1.81 (s, 3H); 1.83 
(s, 3H); 2.18 (d, J = 14.6 Hz, 1H); 2.27 (d, J = 14.6 Hz, 
1H); 2.33 (d, J = 14.6 Hz, 1H); 2.45 (d,  J = 14.6 Hz, 1H); 
2.69 (s, 1H); 3.33 (dd, J1 = 18.3 Hz, J2 = 5.5 Hz, 1H); 3.41 
(td, J1 = 10.6 Hz, J12= 3.9 Hz, 1H); 4.07 (dd, J1 = 18.3 Hz, 
J2 = 4.7 Hz, 1H); 4.44 (s, 1H); 4.72-4.88 (m, 4H); 4.99 (dd, 
J1 = 10.4 Hz, J2 = 1.9 Hz, 1H); 5.15 (dd, J1 = 17.5 Hz, J2 = 
1.9 Hz, 1H); 5.95 (m, 1H). 
13
C NMR (75 MHz, CDCl3):  
22.0 (CH3); 22.5 (CH3); 24.3 (CH3); 24.4 (CH3); 24.7 
(CH2); 26.6 (CH3); 31.1 (CH); 34.9 (CH2); 41.0 (CH2); 
43.1 (CH2); 43.9 (CH); 45.6 (CH2); 47.0 (CH2); 58.0 (C); 
75.9 (CH); 76.5 (C); 87.7 (CH); 113.0 (CH2); 113.2 (CH2); 
114.0 (CH2); 141.5 (CH); 143.2 (C). IR (film): 3550 
(broad), 3070, 1640, 735 cm
-1
. HRMS calcd for C23H40NO2 
[M + H]
+
 362.3054, found 362.3057.  
3-((2S,4aS,7R,8aR)-3-(but-3-en-1-yl)-4,4,7-
trimethyloctahydro-2H-benzo[e][1,3]oxazin-2-yl)penta-
1,4-dien-3-ol (19d). This compound was obtained from 
18a (9.30 g) and purified by flash chromatography 
(hexanes/ethyl acetate 45:1). Yield: 7.90 g, 82%. Colorless 
oil. [α]D
25
 = -47.3 (c = 1.2 CH2Cl2).
 1
H NMR (300 MHz, 
CDCl3):  0.85-0.94 (m, 2H); 0.91 (d,  J = 6.6 Hz, 3H); 
1.06 (m, 1H); 1.15 (s, 3H); 1.18 (s, 3H); 1.48-1.52 (m, 
2H); 1.57 (m, 1H); 1.69 (m, 1H); 1.90 (m, 1H); 2.08-2.21 
(m, 2H); 2.46 (m, 1H); 3.05 (m, 1H); 3.14 (s, 1H); 3.44 (td, 
J1 = 10.5 Hz, J2 = 4.0 Hz, 1H); 4.49 (s, 1H); 4.91-4.99 (m, 
2H); 5.07 (dd, J1 = 10.5 Hz, J2 = 1.8 Hz, 1H); 5.10 (dd, J1 = 
10.5 Hz, J2 = 1.8 Hz, 1H); 5.37 (dd,  J1 = 17.1 Hz, J2 = 1.8 
Hz, 1H); 5.48 (dd, J1 = 17.1 Hz, J2 = 1.8 Hz, 1H); 5.61 (m, 
1H);  6.02 (dd, J1 = 17.1 Hz, J2 = 10.5 Hz, 1H); 6.15 (dd, J1 
= 17.1 Hz, J2 = 10.5 Hz, 1H). 
13
C NMR (75 MHz, CDCl3): 
 22.1 (CH3); 22.9 (CH3); 24.8 (CH2); 26.1 (CH3); 31.3 
(CH); 34.9 (CH2); 37.4 (CH2); 41.0 (CH2); 42.2 (CH2); 
44.5 (CH); 57.8 (C); 74.9 (C); 77.9 (CH); 91.1 (C); 112.0 
(CH2); 112.1 (CH2); 115.2 (CH2); 135.8 (CH); 139.4 (CH); 
141.1 (CH). IR (film): 3460 (broad), 3075, 1640, 735, 630 
cm
-1
. HRMS calcd for C20H34NO2 [M + H]
+
 320.2584, 
found 320.2584. 
4-((2S,4aS,7R,8aR)-3-(but-3-en-1-yl)-4,4,7-
trimethyloctahydro-2H-benzo[e][1,3]oxazin-2-yl)-2,6-
dimethylhepta-1,6-dien-4-ol (19e). This compound was 
obtained from a mixture of 18a and 18b (5.5 g) and 
purified by flash chromatography (hexanes/ethyl acetate 
50:1). Yield: 6.64 g, 95%. Colorless oil. [α]D
25
 = -26.5 (c = 
1.4 CH2Cl2).
 1
H NMR (300 MHz, CDCl3):  
 
0.85-0.96 (m, 
2H); 0.92 (d, J = 6.5 Hz, 3H); 0.97-1.02 (m, 1H); 1.14 (s, 
6H); 1.21-1.51 (m, 2H);  1.59 (m, 1H); 1.68-1.79 (m, 2H); 
1.84 (s, 3H); 1.85 (s, 3H); 2.21 2.44 (m, 6H); 2.63 (m, 1H); 
2.77 (s, 1H); 3.07 (m, 1H); 3.39 (td, J1 = 10.5 Hz, J2 = 3.9 
Hz, 1H); 4.46 (s, 1H); 4.73-4.90 (m, 4H); 4.95 (dd, J1 = 
10.3 Hz, J2 = 1.9 Hz, 1H); 5.02 (dd, J1 = 17.2 Hz, J2 = 1.9 
Hz, 1H); 5.75 (m, 1H). ). 
13
C NMR (75 MHz, CDCl3):  
22.3 (CH3); 22.9 (CH3); 24.6 (CH3); 24.7 (CH3); 25.0 
(CH2); 26.7 (CH3); 31.4 (CH); 35.2 (CH2); 38.0 (CH2); 
41.2 (CH2); 42.9 (CH2); 44.0 (CH2); 44.3 (CH); 46.4 (CH2); 
58.4 (C); 75.7 (C); 77.0 (CH);  88.0 (CH); 113.7 (CH2); 
114.4 (CH2); 115.2 (CH2); 136.6 (CH); 143.4 (C); 143.7 
(C). IR (film): 3548 (broad), 3075, 1640, 730 cm
-1
. HRMS 
calcd for C24H42NO2 [M + H]
+
 376.3210, found 376.3209. 
General procedure for O-allylation of alcohols 3a-d and 
12. To a solution of alcohol 3a-d or 12 (8.0 mmol) in THF 
(40 mL) was added NaH (60% dispersion in mineral oil, 
0.96 g, 24 mmol). The mixture was heated to reflux for 20 
min and cooled to ambient temperature. Allyl bromide or 
methallyl bromide (10.4 mmol) was added, and the 
mixture was again refluxed until the starting material was 
fully consumed as indicated by TLC. After aqueous 
workup, the THF was evaporated and the aqueous residue 
was extracted with diethyl ether (3 x 30 mL). The organic 
extracts were washed with brine, dried over anhydrous 
MgSO4, and the solvent was evaporated in vacuo. The 
residue was chromatographed on silica gel using 
hexanes/AcOEt as an eluent. 
(2S,4aS,7R,8aR)-2-(3-(allyloxy)penta-1,4-dien-3-yl)-3-
benzyl-4,4,7-trimethyloctahydro-2H-
benzo[e][1,3]oxazine (4a). This compound was obtained 
from 3a (2.8 g) and purified by flash chromatography 
(hexanes/ethyl acetate 60:1). Yield: 3.04 g, 98%. Colorless 
oil. [α]D
25
 = -18.5 (c = 1.6 CH2Cl2).
 1
H NMR (300 MHz, 
CDCl3):  0.84-0.95 (m, 2H); 0.86 (s, 3H); 0.94 (d,  J = 6.5 
Hz, 3H); 1.12 (m, 1H); 1.25 (s, 3H); 1.32-1.57 (m, 3H);  
1.69 (m, 1H); 1.96 (m, 1H); 3.53 (td, J1 = 10.5 Hz,  J2 = 3.9 
Hz, 1H); 3.83 (d, J = 18.4 Hz, 1H); 3.89-4.00 (m, 2H); 
4.59 (d, J = 18.4 Hz, 1H); 4.75 (s, 1H); 5.04-5.17 (m, 6H); 
5.84-6.06 (m, 3H);  7.11 (m, 1H); 7.20-7.25 (m, 2H); 7.34-
7.37 (m, 2H). 
13
C NMR (75 MHz, CDCl3):  22.2 (CH3); 
22.5 (CH3); 22.8 (CH2); 26.8 (CH3); 31.4 (CH); 35.1 
(CH2); 41.4 (CH2); 44.1 (CH); 47.5 (CH2); 58.2 (C); 64.4 
(CH2),  77.6 (CH); 82.1 (C); 91.7 (CH); 114.8 (2 CH2); 
116.7 (CH2); 125.2 (CH); 127.1 (2 CH); 127.4 (2 CH); 
135.9 (CH); 137.6 (CH); 137.9 (CH); 144.2 (C). IR (film): 
3080, 2980, 1635, 1450, 720, 695 cm
-1
. HRMS calcd for 
C26H38NO2 [M + H]
+
 396.2897, found 396.2900. 
(2S,4aS,7R,8aR)-3-benzyl-4,4,7-trimethyl-2-(3-((2-
methylallyl)oxy)penta-1,4-dien-3-yl)octahydro-2H-
benzo[e][1,3]oxazine (4b). This compound was obtained 
from 3a (2.8 g) and purified by flash chromatography 
(hexanes/ethyl acetate 50:1). Yield: 2.75 g, 85%. Colorless 
oil. [α]D
25
 = -9.3 (c = 1.3 CH2Cl2).
 1
H NMR (300 MHz, 
CDCl3):  0.83-0.96 (m, 2H); 0.84 (s, 3H);  0.94 (d,  J = 
6.5 Hz, 3H); 1.15 (m, 1H); 1.26 (s, 3H); 1.46-1.72 (m, 4H);  
1.66 (s, 3H); 1.96 (m, 1H); 3.53 (td, J1 = 10.5 Hz,  J2 = 3.9 
Hz, 1H); 3.80-3.90 (m, 3H); 4.58 (d, J = 18.0 Hz, 1H); 
4.78 (s, 1H); 4.79 (d, J = 1.1 Hz, 1H); 5.03-5.31 (m, 5H);  
5.89-6.06 (m, 2H); 7.14 (m, 1H); 7.22-7.24 (m, 2H); 7.34-
7.37 (m, 2H). 
13
C NMR (75 MHz, CDCl3):  19.6 (CH3); 
22.2 (CH3); 22.5 (CH3); 24.8 (CH2); 26.8 (CH3); 31.3 
(CH); 35.1 (CH2); 41.3 (CH2); 44.0 (CH); 47.5 (CH2); 58.2 
(C); 66.8 (CH2),  77.5 (CH); 81.9 (O); 91.7 (CH); 109.6 
(CH2); 114.7 (CH2); 116.7 (CH2); 125.1 (CH); 127.0 (2 
CH); 127.4 (2 CH); 137.6 (CH); 137.9 (CH); 143.1(C); 
144.2 (C). IR (film): 3080, 2925, 1650, 1450, 720, 700 cm
-
1
. HRMS calcd for C27H40NO2 [M + H]
+
 410.3054, found 
410.3054. 
(2S,4aS,7R,8aR)-2-(3-(allyloxy)-2,4-dimethylpenta-1,4-
dien-3-yl)-3-benzyl-4,4,7-trimethyloctahydro-2H-
benzo[e][1,3]oxazine (4c). This compound was obtained 
from 3b (3.0 g) and purified by flash chromatography 
(hexanes/ethyl acetate 60:1). Yield: 2.90 g, 88%. Colorless 
 10 
oil. [α]D
25
 = -18.6 (c = 1.3 CH2Cl2).
 1
H NMR (300 MHz, 
CDCl3):  0.78 (s, 3H); 0.88-0.98 (m, 2H); 0.96 (d,  J = 6.6 
Hz, 3H); 1.04 (m, 1H); 1.29 (s, 3H); 1.54-1.55 (m, 2H);  
1.57 (s, 3H); 1.66-1.75 (m, 2H); 1.78 (s, 3H); 1.83 (m, 
1H); 3.47 (td, J1 = 10.5 Hz,  J2 = 3.9 Hz, 1H); 3.84 (d, J = 
17.5 Hz, 1H); 3.95 (dd, J1 = 14.2 Hz, J2 = 4.6 Hz, 1H); 
4.44 (dd, J1 = 14.2 Hz, J2 = 4.6 Hz, 1H); 4.76 (s, 1H); 5.01-
5.30 (m, 7H); 5.93 (m, 1H); 7.10 (m, 1H); 7.18-7.23 (m, 
2H); 7.27-7.34 (m, 2H). 
13
C NMR (75 MHz, CDCl3):  
19.4 (CH3); 19.9 (CH3); 22.3 (CH3); 22.4 (CH3); 24.9 
(CH2); 27.5 (CH3); 31.5 (CH); 35.3 (CH2); 41.6 (CH2); 
43.3 (CH); 47.3 (CH2); 58.7 (C); 66.6 (CH2);  77.0 (CH); 
85.5 (C); 87.5 (CH); 113.8 (CH2); 113.9 (CH2); 115.3 
(CH2); 124.8 (CH); 127.1 (2 CH); 127.1 (2 CH); 137.0 
(CH); 142.3 (C); 143.8 (C); 146.1 (C). IR (film): 3060, 
2945, 1640, 1450, 720, 695 cm
-1
. HRMS calcd for 
C28H42NO2 [M + H]
+
 424.3210, found 424.3214. 
(2S,4aS,7R,8aR)-3-benzyl-2-(2,4-dimethyl-3-((2-
methylallyl)oxy)penta-1,4-dien-3-yl)-4,4,7-
trimethyloctahydro-2H-benzo[e][1,3]oxazine (4d). This 
compound was obtained from 3b (3.1 g) and purified by 
flash chromatography (hexanes/ethyl acetate 60:1). Yield: 
3.29 g, 93%. Colorless oil. [α]D
25
 = -20.9 (c = 1.0 CH2Cl2).
 
1
H NMR (300 MHz, CDCl3):  
 
0.76 (s, 3H); 0.82-0.99 (m, 
2H); 0.94 (d,, J = 6.6 Hz, 3H); 1.12 (m, 1H); 1.27 (s, 3H); 
1.52-1.76 (m, 4H);  1.54 (s, 3H); 1.70 (s, 3H); 1.75 (s, 3H); 
1.88 (m, 1H); 3.45 (td, J1 = 10.5 Hz,  J2 = 3.9 Hz, 1H); 3.80 
(d, J = 14.0 Hz, 1H); 3.82 (d, J = 17.1 Hz, 1H);  4.37 (d, J 
= 14.0 Hz, 1H); 4.73 (d, J = 1.1 Hz, 2H); 4.92 (d, J = 1.1 
Hz, 1H); 5.07-5.17 (m, 4H); 5.20 (s, 1H); 7.07 (m, 1H); 
7.15-7.20 (m, 2H); 7.24-7.31 (m, 2H). ). 
13
C NMR (75 
MHz, CDCl3):  19.4 (CH3); 19.9 (2 CH3); 22.3 (2 CH3); 
24.9 (CH2); 27.4 (CH3); 31.5 (CH); 35.3 (CH2); 41.6 
(CH2); 43.3 (CH); 47.2 (CH2); 58.6 (C); 69.0 (CH2);  77.0 
(CH); 85.3 (C); 87.7 (CH); 109.2 (CH2); 113.9 (CH2); 
115.3 (CH2); 124.8 (CHar); 127.0 (2 CH); 127.1 (2 CH); 
142.4 (C); 143.8 (C); 144.1 (C); 146.0 (C). IR (film): 3065, 
2915, 1635, 1450, 720, 695 cm
-1
. HRMS calcd for 
C29H44NO2 [M + H]
+
 438.3367, found 438.3377. 
(2S,4aS,7R,8aR)-2-(4-(allyloxy)hepta-1,6-dien-4-yl)-3-
benzyl-4,4,7-trimethyloctahydro-2H-
benzo[e][1,3]oxazine (4e). This compound was obtained 
from 3c (3.1 g) and purified by flash chromatography 
(hexanes/ethyl acetate 50:1). Yield: 3.15 g, 92%. Colorless 
oil. [α]D
25
 = +40.6 (c = 1.7 CH2Cl2).
 1
H NMR (300 MHz, 
CDCl3):  0.82-1.01 (m, 2H); 0.89 (s, 3H); 0.96 (d, J = 6.5 
Hz, 3H); 1.12 (m, 1H); 1.24 (s, 3H); 1.43-1.62 (m, 3H); 
1.70 (m, 1H); 1.92 (m, 1H); 2.27 (dd, J1 = 14.0 Hz, J2 = 6.9 
Hz, 1H); 2.36 (dd, J1 = 14.0 Hz, J2 = 7.4 Hz, 1H); 2.43 (dd,  
J1 = 14.4 Hz, J2 = 8.5 Hz, 1H); 2.67 (dd, J1 = 14.4 Hz, J2 = 
5.4 Hz, 1H); 3.37 (td, J1 = 10.4 Hz, J2 = 4.0 Hz, 1H); 3.92 
(d, J = 18.4 Hz, 1H); 4.07 (dd, J1 = 13.2 Hz, J2 = 5.1 Hz, 
1H); 4.43 (dd, J1 = 13.2 Hz, J2 = 5.3 Hz, 1H); 4.48 (s, 1H); 
4.95-5.16 (m, 7H);  5.75-5.98 (m, 3H); 7.14 (m, 1H); 7.21-
7.27 (m, 2H); 7.31-7.45 (m, 2H). 
13
C NMR (75 MHz, 
CDCl3):  22.3 (CH3); 22.4 (CH3); 24.8 (CH2); 26.7 (CH3); 
31.3 (CH2); 35.1 (CH2); 37.0 (CH2); 39.4 (CH2); 41.6 
(CH2); 43.9 (CH); 46.6 (CH2); 58.3 (C); 64.8 (CH2);  77.5 
(CH); 80.3 (C); 89.9 (CH); 114.5 (CH2); 117.6 (2 CH2); 
125.1 (CH); 126.5 (2 CH); 127.6 (2 CH); 134.2 (CH); 
134.6 (CH); 136.1 (CH); 144.8 (C). IR (film): 3075, 2925, 
1640, 1450, 725, 695 cm
-1
. HRMS calcd for C28H42NO2 [M 
+ H]
+
 424.3210, found 424.3217. 
(2S,4aS,7R,8aR)-2-(4-(allyloxy)-2,6-dimethylhepta-1,6-
dien-4-yl)-3-benzyl-4,4,7-trimethyloctahydro-2H-
benzo[e][1,3]oxazine (4f). This compound was obtained 
from 3d (3.2 g) and purified by flash chromatography 
(hexanes/ethyl acetate 50:1). Yield: 3.37 g, 96%. Colorless 
oil. [α]D
25
 = -5.1 (c = 1.2 CH2Cl2).
 1
H NMR (300 MHz, 
CDCl3):   0.86-0.98 (m, 2H); 0.90 (s, 3H); 0.94 (d, J = 6.5 
Hz, 3H); 1.11 (m, 1H); 1.22 (s, 3H); 1.35-1.56 (m, 3H);  
1.60 (s, 3H); 1.72 (m, 1H); 1.82 (s, 3H); 1.88 (m, 1H); 2.23 
(d, J = 15.0 Hz, 1H); 2.40 (d, J = 14.1 Hz, 1H); 2.56 (d, J = 
15.0 Hz, 1H); 2.69 (d, J = 14.1 Hz, 1H); 3.36 (td, J1 = 10.5 
Hz, J2 = 4.0 Hz, 1H); 3.92 (d, J = 18.2 Hz, 1H); 4.14 (dd, 
J1 = 13.2 Hz, J2 = 4.9 Hz, 1H); 4.49 (dd, J1 = 13.2 Hz, J2 = 
5.1 Hz, 1H); 4.58 (s, 1H); 4.81 (s, 2H); 4.90 (s, 2H); 4.91-
5.06 (m, 2H);  5.83 (m, 1H); 7.11 (m, 1H); 7.21-7.27 (m, 
2H); 7.40-7.42 (m, 2H). 
13
C NMR (75 MHz, CDCl3):  
22.3 (CH3); 22.6 (CH3); 24.9 (CH2); 25.1 (2CH3); 26.8 
(CH3); 31.4 (CH); 35.2 (CH2); 38.7 (CH2); 41.5 (CH2); 
42.0 (CH2); 44.0 (CH); 46.7 (CH2); 58.6 (C); 64.7 (CH2);  
77.0 (CH); 82.0 (C); 89.8 (CH); 114.0 (CH2); 114.4 (CH2); 
114.6 (CH2); 125.1 (CH); 126.9 (2 CH); 127.6 (2 CH); 
136.4 (CH); 142.7 (C); 143.6 (C); 145.0 (C). IR (film): 
3075, 2920, 1640, 1450, 720, 670 cm
-1
. HRMS calcd for 
C30H46NO2 [M + H]
+
 452.3523, found 452.3532. 
(2S,4aS,7R,8aR)-3-benzyl-2-(2,6-dimethyl-4-((2-
methylallyl)oxy)hepta-1,6-dien-4-yl)-4,4,7-
trimethyloctahydro-2H-benzo[e][1,3]oxazine (4g). This 
compound was obtained from 3d (3.1 g) and purified by 
flash chromatography (hexanes/ethyl acetate 55:1). Yield: 
3.26 g, 93%. Colorless oil. [α]D
25
 = +2.3 (c = 1.7 CH2Cl2).
 
1
H NMR (300 MHz, CDCl3):   0.85-1.01  (m, 2H); 0.90 (s, 
3H); 0.94 (d,  J = 6.5 Hz, 3H); 1.14 (m, 1H); 1.22 (s, 3H); 
1.35-1.61 (m, 2H);  1.59 (s, 3H); 1.66 (s, 3H); 1.68 (m, 
1H); 1.83 (s, 3H); 1.89 (m, 1H); 2.22 (d, J = 15.0 Hz, 1H); 
2.38 (d, J = 13.9 Hz, 1H); 2.57 (d, J = 15.0 Hz, 1H); 2.74 
(d, J = 13.9 Hz, 1H); 3.35 (td, J1 = 10.5 Hz, J2 = 3.9 Hz, 
1H); 3.91 (d, J = 18.3 Hz, 1H); 3.99 (d, J = 12.7 Hz, 1H); 
4.40 (d, J = 12.7 Hz, 1H); 4.59 (s, 1H); 4.72 (d, J = 0.9 
Hz); 4.79 (s, 1H); 4.80 (s, 1H); 4.83 (s, 1H); 4.90 (s, 1H);  
5.00 (d, J = 18.3 Hz, 1H); 7.17 (m, 1H); 7.31-7.40 (m, 
2H); 7.2-7.47 (m, 2H). 
13
C NMR (75 MHz, CDCl3):  20.1 
(CH3); 22.3 (CH3); 22.6 (CH3); 24.9 (CH2); 25.1 (CH3); 
25.2 (CH3); 26.8 (CH3); 31.4 (CH); 35.2 (CH2); 38.6 
(CH2); 41.6 (CH2); 42.1 (CH2); 44.0 (CH); 46.7 (CH2); 
58.5 (C); 67.3 (CH2);  76.9 (CH); 82.0 (C); 89.8 (CH); 
110.0 (CH2); 114.0 (CH2); 114.7 (CH2); 125.0 ( CH); 126.9 
(2 CH); 127.5 (2 CH); 142.8 (C); 143.6 (C); 143.7 (C); 
145.0 (C). IR (film): 3075, 1640, 720, 695 cm
-1
. HRMS 
calcd for C31H48NO2 [M + H]
+
 466.3680, found 466.3687. 
(2S,4aS,7R,8aR)-2-((R)-3-(allyloxy)pent-1-en-3-yl)-3-
benzyl-4,4,7-trimethyloctahydro-2H-
benzo[e][1,3]oxazine (13). This compound was obtained 
from 12 (2.2 g) and purified by flash chromatography 
(hexanes/ethyl acetate 45:1). Yield: 2.35 g, 96%. Colorless 
oil. [α]D
25
 = -11.3 (c = 1.3 CH2Cl2).
 1
H NMR (300 MHz, 
CDCl3):   0.8 (t, J = 7.4 Hz 3H,); 0.87 (s, 3H); 0.89-1.11 
(m, 2H) 0.94 (d, J = 6.5 Hz, 3H); 1.17 (m, 1H); 1.28 (s, 3H, 
CH3); 1.42-1.63 (m, 3H);  1.64-1.73 (m, 3H); 1.90 (m, 
1H); 3.46 (td, J1 = 10.6 Hz, J2 = 3.7 Hz, 1H); 3.82 (d, J = 
17.9 Hz, 1H); 4.14 (m, 1H); 4.34 (m, 1H); 4.76  (s, 1H); 
4.84 (d, J = 17.9 Hz, 1H); 5.03-5.14 (m, 2H); 5.14-5.25 (m, 
2H); 5.85-5.95 (m, 2H); 7.11 (m, 1H); 7.19-7.24 (m, 2H); 
7.36-7.39 (m, 2H). 
13
C NMR (75 MHz, CDCl3):  7.4 
(CH3); 22.3 (2CH3); 24.9 (CH2); 27.1 (CH3); 28.1 (CH2); 
35.5 (CH); 35.2 (CH2); 41.5 (CH2); 44.1 (CH); 47.5 
(CH2); 58.3 (C); 63.8 (CH2),  77.8 (CH); 80.5 (C); 90.0 
(CH); 114.6 (CH2); 115.0 (CH2); 125.1 (CH); 127.0 (2 
CH); 127.5 (2 CH); 136.3 (CH); 138.9 (CH); 144.2 (C). IR 
(film): 3064, 1452, 721, 695 cm
-1
. HRMS calcd for 
C26H40NO2 [M + H]
+
 398.3054, found 398.3054 
General procedure for methylation of alcohols 19a-e. 
To a solution of alcohols 19a-e (9.0 mmol) in THF (45 
mL) was added NaH (60% dispersion in mineral oil, 1.1 g, 
27 mmol). The mixture was heated to reflux for 20 min 
and cooled to ambient temperature. Iodomethane (1.8 mL, 
28.8 mmol) was added, and the mixture was again refluxed 
until the starting material was fully consumed as indicated 
by TLC. After aqueous workup, the THF was evaporated 
and the aqueous residue was extracted with ethyl acetate (3 
x 40 mL). The organic extracts were washed with brine, 
dried over anhydrous MgSO4, and the solvent was 
evaporated in vacuo. The residue was chromatographed on 
silica gel using hexanes/AcOEt as an eluent. 
(2S,4aS,7R,8aR)-3-allyl-2-(3-methoxypenta-1,4-dien-3-
yl)-4,4,7-trimethyloctahydro-2H-benzo[e][1,3]oxazine 
(20a). This compound was obtained from 19a (2.75 g) and 
purified by flash chromatography (hexanes/ethyl acetate 
50:1). Yield: 2.82 g, 98%. Colorless oil. [α]D
25
 = -49.2 (c = 
1.2 CH2Cl2).
 1
H NMR (300 MHz, CDCl3):  0.86-0.96 (m, 
 11 
2H); 0.91 (d, J = 6.5 Hz, 3H); 1.07 (s, 3H); 1.10 (m, 1H); 
1.16 (s, 3H); 1.21-1.57 (m, 3H);  1.68 (m, 1H); 1.93 (m, 
1H); 3.19 (s, 3H); 3.32 (dd, J1 = 17.9 Hz, J2 = 5.3 Hz, 1H); 
3.45 (td, J1 = 10.6 Hz, J2 = 3.9 Hz, 1H); 3.83 (dd, J1 = 17.9 
Hz, J2 = 5.3 Hz, 1H); 4.57 (s, 1H); 4.91 (dd, J1 = 10.3 Hz, 
J2 = 1.9 Hz, 1H); 5.03 (dd, J1 = 17.4 Hz, J2 = 1.9 Hz, 1H); 
5.20-5.34 (m, 4H); 5.85-6.05 (m 3H). 
13
C NMR (75 MHz, 
CDCl3):  22.1 (CH3); 22.5 (CH3); 24.9 (CH2); 26.4 (CH3); 
31.3 (CH); 35.1 (CH2); 41.3 (CH2); 44.7 (CH); 46.4 (CH2); 
51.4 (CH3); 57.8 (C); 77.4 (CH); 82.0 (C); 91.3 (CH); 
112.7 (CH2); 115.2 (CH2); 117.2 (CH2); 136.9 (CH); 137.9 
(CH); 141.8 (CH). IR (film): 3085, 1635, 830 cm
-1
. HRMS 
calcd for C20H34NO2 [M + H]
+
 320.2584, found 320.2587. 
(2S,4aS,7R,8aR)-3-allyl-2-(3-methoxy-2,4-
dimethylpenta-1,4-dien-3-yl)-4,4,7-trimethyloctahydro-
2H-benzo[e][1,3]oxazine (20b). This compound was 
obtained from 19b (3.0 g) and purified by flash 
chromatography (hexanes/ethyl acetate 75:1). Yield: 2.80 g, 
89%. Colorless oil. [α]D
25
 = -5.8 (c = 1.0 CH2Cl2).
 1
H NMR 
(300 MHz, CDCl3):   0.87-0.94 (m, 2H); 0.92 (d, J = 6.5 
Hz, 3H); 1.05 (m, H); 1.06 (s, 3H); 1.18 (s, 3H); 1.26-1.55 
(m, 2H); 1.57 (s, 3H); 1.65 (s, 3H); 1.69 (m, 1H); 1.86 (m, 
1H); 3.31-3.48 (m, 2H); 3.38 (s, 3H); 4.16 (dd, J1 = 17.3 
Hz, J2 = 4.5 Hz, 1H); 4.77-4.94 (m, 3H); 5.02 (s, 1H); 
5.13-6.00 (m, 3H); 6.04 (m, 1H). 
13
C NMR (75 MHz, 
CDCl3):  19.6 (CH3); 19.8 (CH3); 22.3 (CH3); 22.4 (CH3); 
25.1 (CH2); 27.2 (CH3); 31.5 (CH); 35.2 (CH2); 41.7 
(CH2); 44.4 (CH); 46.7 (CH2); 53.9 (CH3); 58.4 (C); 77.0 
(CH); 85.5 (C); 87.7 (CH); 111.0 (CH2); 112.5 (CH2); 
115.6 (CH2); 143.4 (C); 143.9 (C); 144.3 (CH). IR (film): 
3070, 1640, 830, 730 cm
-1
. HRMS calcd for C22H38NO2 [M 
+ H]
+
 348.2897, found 348.2900. 
(2S,4aS,7R,8aR)-3-allyl-2-(4-methoxy-2,6-
dimethylhepta-1,6-dien-4-yl)-4,4,7-trimethyloctahydro-
2H-benzo[e][1,3]oxazine (20c). This compound was 
obtained from 19c (3.0 g) and purified by flash 
chromatography (hexanes/ethyl acetate 75:1). Yield: 2.80 g, 
90%. Colorless oil. [α]D
25
 = -41.4 (c = 1.0 CH2Cl2).
 1
H 
NMR (300 MHz, CDCl3):  0.86-0.96 (m, 2H); 0.91 (d, J = 
6.5 Hz, 3H); 1.05 (m, 1H); 1.09 (s, 3H); 1.11 (s, 3H); 1.42-
1.59 (m, 3H);  1.70 (m, 1H); 1.78 (s, 3H); 1.82 (s, 3H); 
1.84 (m, 1H); 2.21 (d,  J= 15.0 Hz, 1H); 2.42 (d, J = 14.2 
Hz, 1H); 2.57 (d, J= 15.0 Hz, 1H); 2.64 (d, J= 14.2 Hz, 
1H); 3.28 (td, J1 = 10.4 Hz, J2 = 3.9 Hz, 1H); 3.41 (s, 3H); 
3.43 (dd, J1 = 17.7 Hz, J2 = 5.4 Hz, 1H); 4.11 (dd, J1 = 17.7 
Hz, J2 = 5.4 Hz, 1H); 4.41 (s, 1H); 4.80-4.86 (m, 4H); 4.94 
(dd, J1 = 10.3 Hz, J2 = 1.9 Hz, 1H); 5.10 (dd, J1 = 17.3 Hz, 
J2 = 1.9 Hz, 1H); 6.04 (m, 1H). 
13
C NMR (75 MHz, 
CDCl3):  22.2 (CH3); 22.4 (CH3); 24.8 (CH3); 24.9 (CH2); 
25.2 (CH3); 26.8 (CH3); 31.4 (CH); 35.2 (CH2); 38.3 
(CH2); 41.4 (CH2); 41.5 (CH2); 44.3 (CH); 46.0 (CH2); 
51.2 (CH3); 58.3 (C); 76.6 (CH); 81.5 (C); 89.6 (CH); 
112.6 (CH2); 114.1 (2 CH2); 142.4 (CH); 142.7 (C); 143.1 
(C). IR (film): 3075, 1640, 890, 785 cm
-1
. HRMS calcd for 
C24H42NO2 [M + H]
+
 376.3210, found 376.3209. 
(2S,4aS,7R,8aR)-3-(but-3-en-1-yl)-2-(3-methoxypenta-
1,4-dien-3-yl)-4,4,7-trimethyloctahydro-2H-
benzo[e][1,3]oxazine (20d). This compound was obtained 
from 19d (3.0 g) and purified by flash chromatography 
(hexanes/ethyl acetate 50:1). Yield: 2.91 g, 93%. Colorless 
oil. [α]D
25
 = -69.6 (c = 1.4 CH2Cl2).
 1
H NMR (300 MHz, 
CDCl3):  0.88 (m, 2H); 0.90 (d, J = 6.5 Hz, 3H); 1.03 (m, 
1H); 1.13 (s, 3H, CH3); 1.16 (s, 3H, CH3); 1.39-1.47 (m, 
2H); 1.32 (m, 1H); 1.67 (m, 1H); 1.91 (m, 1H); 2.12 (m, 
1H); 2.29 (m, 1H); 2.55 (m, 1H); 3.12 (m, 1H); 3.23 (s, 
3H); 3.44 (td, J1 = 10.6 Hz, J2 = 3.8 Hz, 1H); 4.57 (s, 1H); 
4.91 (dd, J1= 9.9 HZ, J2= 2.0 Hz, 1H); 4.96 (m, 1H); 5.22-
5.35 (m, 4H); 5.66 (m, 1H);  5.96 (dd, J1 = 17.6 Hz, J2 = 
9.9 Hz, 1H); 6.05 (dd,  J1 = 17.6 Hz, J2 = 9.9 Hz, 1H). ). 13
C NMR (75 MHz, CDCl3):  22.2 (CH3); 22.5 (CH3); 
25.1 (CH2); 26.2 (CH3); 31.4 (CH); 35.1 (CH2); 37.3 
(CH2); 41.4 (CH2); 43.0 (CH2); 44.9 (CH); 51.4 (CH3); 
57.6 (C); 77.5 (CH); 81.5 (C); 90.8 (CH); 114.7 (CH2); 
115.0 (CH2); 116.9 (CH2); 136.9 (CH); 137.2 (CH); 140.0 
(CH). IR (film): 3075, 1640, 1455, 915 cm
-1
. HRMS calcd 
for C21H36NO2 [M + H]
+
 334.2741, found 334.2747. 
(2S,4aS,7R,8aR)-3-(but-3-en-1-yl)-2-(4-methoxy-2,6-
dimethylhepta-1,6-dien-4-yl)-4,4,7-trimethyloctahydro-
2H-benzo[e][1,3]oxazine (20e). This compound was 
obtained from 19e (2.1 g) and purified by flash 
chromatography (hexanes/ethyl acetate 80:1). Yield: 2.12 g, 
97%. Colorless oil. [α]D
25
 = -52.6 (c = 1.2 CH2Cl2).
 1
H 
NMR (300 MHz, CDCl3):  0.84-0.91 (m, 2H); 0.90 (d, J = 
6.5 Hz, 3H); 0.98 (m, 1H); 1.09 (s, 3H); 1.14 (s, 3H); 1.17-
1.79 (m, 4H);  1.81 (s, 3H); 1.82 (s, 3H); 1.83 (m, 1H); 
2.16 (d, J = 14.4 Hz, 1H); 2.25 (m, 1H); 2.44 (d, J = 14.4 
Hz, 1H); 2.48-2.62 (m, 2H); 2.63 (d, J = 14.4 Hz, 1H); 
2.69 (d, J = 14.4 Hz, 1H); 3.26 (td, J1 = 10.3 Hz, J2 = 4.0 
Hz, 1H); 3.33 (m, 1H); 3.41 (s, 3H); 4.33 (s, 1H); 4.84-
5.16 (m, 6H); 5.53 (m, 1H) 
13
C NMR (75 MHz, CDCl3):  
22.3 (CH3); 22.6 (CH3); 25.1 (2CH3); 25.3 (CH2); 26.5 
(CH3); 31.5 (CH); 35.2 (CH2); 37.9 (CH2); 38.2 (CH2); 
41.5 (CH2); 41.8 (CH2); 43.2 (CH2); 44.5 (CH); 51.5 (CH3); 
58.2 (C); 76.9 (CH); 81.4 (C); 89.7 (CH); 114.1 (CH2); 
114.4 (CH2); 114.6 (CH2); 137.6 (CH); 142.8 (C); 143.4 
(C). IR (film): 3075, 1640, 750 cm
-1
. HRMS calcd for 
C25H44NO2 [M + H]
+
 390.3367, found 390.3376. 
General procedure for silylation of alcohols 19a-e.  To a 
solution of alcohols 19a-e (4.5 mmol) and 2,6-lutidine (1.1 
mL, 9.0 mmol) in anhydrous CH2Cl2 (25 mL) was 
dropwise added tert-butyldimethylsilyl-triflate (1.7 mL, 
7.2 mmol). The solution was stirred at room temperature 
until the starting material was fully consumed as indicated 
by TLC (for total transformation of alcohols 19b, 19c and 
19e it was necessary to add an extra amount of 2,6-
lutidine ,0.3 mL, and TBSOTf, 0.45 mL). The reaction 
liquid was diluted with CH2Cl2 (60 mL), then washed with 
water, aqueous saturated ammonium chloride solution and 
aqueous saturated sodium chloride solution, then dried 
over anhydrous magnesium sulphate and concentrated. The 
residue was purified through silica gel column 
chromatography using hexanes/ ethyl acetate as an eluent. 
(2S,4aS,7R,8aR)-3-allyl-2-(3-((tert-
butyldimethylsilyl)oxy)penta-1,4-dien-3-yl)-4,4,7-
trimethyloctahydro-2H-benzo[e][1,3]oxazine (21a). This 
compound was obtained from 19a (1.4 g) and purified by 
flash chromatography (hexanes/ethyl acetate 100:1). Yield: 
1.85 g, 96%. Colorless oil. [α]D
25
 = -34.5 (c = 1.0 CH2Cl2).
 
1
H NMR (300 MHz, CDCl3):   0.08 (s, 3H); 0.10 (s, 3H);  
0.85-90 (m, 2H); 0.89 (s, 9H); 0.93 (d, J = 6.5 Hz, 3H); 
1.04 (s, 3H); 1.08 (m, 1H); 1.14 (s, 3H); 1.42-1.58 (m, 
3H);  1.69 (m, 1H); 1.90 (m, 1H); 3.25 (dd, J1 = 17.7 Hz, 
J2 = 6.0 Hz, 1H); 3.43 (td,  J1 = 10.6 Hz, J2 = 3.9 Hz, 1H); 
3.88 (dd, J1 = 17.7 Hz, J2 = 5.0 Hz, 1H); 4.45 (s, 1H); 4.85 
(dd, J1 = 10.6 Hz, J2 = 1.8 Hz, 1H); 4.93 (dd, J1 = 17.4 Hz, 
J2 = 1.8 Hz, 1H); 5.11 (dd, J1 = 10.6 Hz, J2 = 1.8 Hz, 1H); 
5.16 (dd, J1 = 10.6 Hz, J2 = 1.8 Hz, 1H); 5.28 (dd, J1 = 17.4 
Hz, J2 = 1.8 Hz, 1H); 5.29 (dd, J1 = 17.4 Hz, J2 = 1.8 Hz, 
1H);5.89 (m, 1H);  6.06 (dd, J1 = 17.4 Hz, J2 = 10.6 Hz, 
1H); 6.12 (dd, J1 = 17.4 Hz, J2 = 10.6 Hz, 1H). 
13
C NMR 
(75 MHz, CDCl3):  -1.9 (2 CH3); 18.7 (C); 22.4 (CH3); 
22.8 (CH3); 25.0 (CH2); 26.1 (3 CH3); 26.9 (CH3); 31.5 
(CH); 35.2 (CH2); 41.4 (CH2); 41.5 (CH); 46.6 (CH2); 57.9 
(C); 77.3 (CH); 80.0 (C); 91.1 (CH); 112.2 (CH2); 114.2 
(CH2); 114.5 (CH2); 139.7 (CH); 141.3 (CH); 142.8 (CH). 
IR (film): 3080, 1635, 835, 780, 685 cm
-1
. HRMS calcd for 
C25H46NO2Si [M + H]
+
 420.3292, found 420.3292. 
(2S,4aS,7R,8aR)-3-allyl-2-(3-((tert-
butyldimethylsilyl)oxy)-2,4-dimethylpenta-1,4-dien-3-
yl)-4,4,7-trimethyloctahydro-2H-benzo[e][1,3]oxazine 
(21b). This compound was obtained from 19b (1.65 g) and 
purified by flash chromatography (hexanes/CH2Cl2 3:1). 
Yield: 1.33 g, 60%. White solid. Mp 53-54 ºC (from 
hexane). [α]D
25
 = -2.0 (c = 1.0 CH2Cl2).
 1
H NMR (300 
MHz, CDCl3):   0.07 (s, 3H); 0.23 (s, 3H); 0.87-1.05 (m, 
2H); 0.91 (s, 9H, 3CH3); 0.94 (d, 3H, J = 6.5 Hz); 1.02 (s, 
3H); 1.16 (m, 1H); 1.20 (s, 3H); 1.38-1.60 (m, 3H);  1.64 
(s, 6H); 1.73 (m, 1H); 1.87 (m, 1H); 3.12 (dd,  J1 = 17.3 Hz, 
J2 = 7. 6 Hz, 1H); 3.51 (td, J1 = 10.6 Hz, J2 = 3.8 Hz, 1H); 
4.19 (m, 1H); 4.71 (m, 1H); 4.82-4.88 (m, 2H); 4.97 (s, 
1H); 4.98-5.00 (m, 2H); 5.30 (m, 1H); 5.77 (m, 1H). 
13
C 
NMR (75 MHz, CDCl3):  -3.7 (CH3); -1.3 (CH3);  18.1 
(C); 19.4 (CH3); 19.9 (CH3); 22.4 (CH3); 22.5 (CH3); 25.1 
 12 
(CH2); 26.8 (3 CH3); 27.9 (CH3); 31.7 (CH); 35.3 (CH2); 
41.4 (CH2); 43.8 (CH); 47.5 (CH2); 58.4 (C); 76.9 (CH); 
84.9 (CH); 85.5 (C); 110.2 (CH2); 112.1 (CH2); 113.7 
(CH2); 144.5 (CH); 144.7 (C); 146.4 (C). IR (nujol 
dispersion): 3070, 1638, 835, 687 cm
-1
. HRMS calcd for 
C27H50NO2Si [M + H]
+
 448.3605, found 448.3617. 
(2S,4aS,7R,8aR)-3-allyl-2-(4-((tert-
butyldimethylsilyl)oxy)-2,6-dimethylhepta-1,6-dien-4-
yl)-4,4,7-trimethyloctahydro-2H-benzo[e][1,3]oxazine 
(21c). This compound was obtained from 19c (1.7 g) and 
purified by flash chromatography (hexanes/ ethyl acetate 
100:1). Yield: 1.75 g, 78%. Colorless oil. [α]D
25
 = -31.0 (c 
= 1.5 CH2Cl2).
 1
H NMR (300 MHz, CDCl3):  0.12 (s, 
3H); 0.22 (s, 3H); 0.86-1.04 (m, 2H); 0.89 (s, 9H); 0.94 (d, 
J = 6.5 Hz, 3H); 1.05 (s, 3H); 1.09 (m, 1H); 1.12 (s, 3H); 
1.45-1.58 (m, 3H);  1.70 (m, 1H); 1.83 (s, 6H); 1.88 (m, 
1H); 2.16 (d, J = 14.5 Hz, 1H); 2.52 (d, J = 13.8 Hz, 1H); 
2.66 (d, 1H, J = 13.8 Hz); 2.68 (d, J = 14.5 Hz, 1H); 3.25 
(dd, J1 = 18.2 Hz, J2 = 5.7 Hz, 1H); 3.39 (td, J1  = 10.6 Hz, 
J2 = 3.8 Hz, 1H); 4.41 (s, 1H); 4.42 (dd, J1 = 18.2 Hz, J2 = 
4.2 Hz, 1H); 4.85-4.96 (m, 5H); 5.11 (dd, J1 = 17.4 Hz, J2 
= 1.8 Hz, 1H); 5.98 (m, 1H). 
13
C NMR (75 MHz, CDCl3): 
 -0.9 (2 CH3); 19.1 (C); 22.4 (CH3); 22.9 (CH3); 25.0 
(CH2); 25.1 (CH3); 26.2 (CH3); 26.6 (3CH3); 27.1 (CH3); 
31.5 (CH); 35.3 (CH2); 41.3 (CH2); 42.1 (CH2); 43.7 (CH); 
45.0 (CH2); 46.4 (CH2); 58.2 (C); 76.5 (CH); 81.9 (C); 
86.9 (CH); 112.4 (CH2); 114.6 (CH2); 115.0 (CH2); 142.7 
(CH); 142.9 (2C). IR (film): 3075, 1640, 775, 700, 670 cm
-
1
. HRMS calcd for C29H54NO2Si [M + H]
+
 476.3918, found 
476.3917. 
(2S,4aS,7R,8aR)-3-(but-3-en-1-yl)-2-(3-((tert-
butyldimethylsilyl)oxy)penta-1,4-dien-3-yl)-4,4,7-
trimethyloctahydro-2H-benzo[e][1,3]oxazine (21d). This 
compound was obtained from 19d (1.0 g) and purified by 
flash chromatography (hexanes/ ethyl acetate 100:1). 
Yield: 1.33 g, 98%. Colorless oil. [α]D
25
 = -27.1 (c = 1.0 
CH2Cl2).
 1
H NMR (400 MHz, CDCl3):  0.09 (s, 6H), 
0.84-0.95 (m 2H), 0.89 (s, 9H), 0.90 (d, 3H, J = 6.5 Hz), 
1.07 (m, 1H), 1.09 (s, 3H), 1.13 (s, 3H), 1.39-1.48 (m, 2H), 
1.55 (m, 1H), 1.67 (m, 1H), 1.88 (m, 1H), 2.06 (m, 1H), 
2.23 (m, 1H), 2.46 (m, 1H), 3.19 (m, 1H), 3.41 (td, J1 = 
10.4 Hz, J2 = 3.8 Hz, 1H), 4.43 (s, 1H), 4.84-4.93 (m, 2H), 
5.10 (d, J = 10.6 Hz, 1H), 5.15 (d, J = 10.6 Hz, 1H), 5.25-
5.35 (m, 2H), 5.62 (m, 1H), 6.02 (dd, J1 = 17.3 Hz, J2 = 
10.6 Hz, 1H), 6.14 (dd, J1 = 17.3 Hz, J2 = 10.6 Hz, 1H). 13
C NMR (75 MHz, CDCl3):  -1.8 (2 CH3); 18.3 (C); 22.4 
(CH3); 22.9 (CH3); 25.2 (CH2); 26.1 (3 CH3); 26.4 (CH3); 
31.5 (CH); 35.3 (CH2); 37.8 (CH2); 41.4 (CH2); 43.0 
(CH2); 44.4 (CH); 57.5 (C); 77.4 (CH); 79.9 (C); 91.1 
(CH); 114.0 (CH2); 114.2 (CH2); 114.7 (CH2); 137.0 (CH); 
140.4 (CH); 141.3 (CH). IR (film): 3080, 2925, 1640, 1470, 
1460, 835, 780, 685 cm
-1
. HRMS calcd for C26H48NO2Si 
[M + H]
+
 434.3449, found 434.3456. 
(2S,4aS,7R,8aR)-3-(but-3-en-1-yl)-2-(4-((tert-
butyldimethylsilyl)oxy)-2,6-dimethylhepta-1,6-dien-4-
yl)-4,4,7-trimethyloctahydro-2H-benzo[e][1,3]oxazine 
(21e). This compound was obtained from 19e (1.14 g) and 
purified by flash chromatography (hexanes/ ethyl acetate 
100:1). Yield: 1.23 g, 83%. Colorless oil. [α]D
25
 = -35.3 (c 
= 1.5 CH2Cl2).
 1
H NMR (300 MHz, CDCl3):  0.12 (s, 
3H); 0.19 (s, 3H); 89-1.04 (m, 3H); 0.91 (s, 9H); 0.93 (d, 
3H, J = 6.6 Hz); 1.08 (m, 1H); 1.10 (s, 3H); 1.12 (s, 3H); 
1.32-1.62(m, 3H); 1.71 (m, 1H); 1.82 (s, 3H); 1.84 (m, 
1H); 1.89 (s, 3H); 2.17 (d, 1H, J = 14.6 Hz); 2.28 (m, 1H); 
2.38-2.50 (m, 3H); -2.61-2.72 (m, 2H), 3.38 (td, 1H,  J1 = 
10.6 Hz, J2 = 3.6 Hz); 3.68 (m, 1H); 3.36 (s, 1H); 4.85-
5.04 (m, 6H); 5.78 (m, 1H). 
13
C NMR (75 MHz, CDCl3):  
-0.91 (2 CH3); 19.2 (C); 22.3 (CH3); 23.0 (CH3); 25.0 
(CH2); 25.1 (CH3); 26.3 (CH3); 26.6 (3CH3); 26.8 (CH3); 
31.5 (CH); 35.2 (CH2); 38.3 (CH2); 41.2 (CH2); 42.4 
(CH2); 43.1 (CH2); 43.5 (CH); 45.0 (CH2); 58.1 (C); 76.5 
(CH); 81.8 (C); 87.1 (CH); 114.8 (2 CH2); 115.0 (CH2); 
137.2 (CH); 142.9 (C); 143.0 (C). IR (film): 3080, 2950, 
1640, 1460, 835, 775 cm
-1
. HRMS calcd for C30H56NO2Si 
[M + H]
+
 490.4075, found 490.4078. 
General procedure for DSRCM Reaction of trienes 4a-
g, 19a-e, 20a-e, 21a-e and diene 14. The triene (3 mmol) 
was dissolved in dry CH2Cl2 (90 mL) and argon was 
bubbled. Grubbs first- or second-generation catalyst (0.06 
mmol) was added and the resulting mixture was stirred at 
room temperature or at reflux under argon. The reaction 
progress was monitored by TLC and additional portions of 
fresh catalyst were added after the times indicated in 
Tables 1 and 2. When the reaction was found to be 
complete the solvent was evaporated in vacuo and the 
residue was purified by flash chromatography on silica gel 
using mixtures of hexanes/ethyl acetate as eluent. 
(2S,4aS,7R,8aR)-3-benzyl-4,4,7-trimethyl-2-((R)-2-
vinyl-2,5-dihydrofuran-2-yl)octahydro-2H-
benzo[e][1,3]oxazine (7a). This compound was obtained 
from 4a (1.2 g) and catalyst 5, and purified by flash 
chromatography (hexanes/ ethyl acetate 45:1). Yield: 0.62 
g, 56%.  Colorless oil. [α]D
25
 = -32.9 (c = 1.8, CHCl3).
 1
H 
NMR (300 MHz, CDCl3):  0.84-1.02 (m, 2H), 0.87 (s, 
3H); 0.93 (d, J = 6.5 Hz, 3H); 1.14 (m, 1H); 1.27 (s, 3H); 
1.34-1.50 (m, 3H); 1.60 (m, 1H); 1.94 (m, 1H); 3.51 (td,  J1 
= 10.5 Hz, J2 = 3.9 Hz, 1H); 3.87 (d, J = 18.3 Hz, 1H); 
4.45-4.52 (m, 2H); 4.58 (d,  J = 18.3 Hz, 1H); 4.78 (s, 1H);  
4.97 (dd, J1 = 10.7 Hz, J2 = 1.7 Hz, 1H); 5.02 ((dd, J1 = 
17.3 Hz, J2 = 1.7 Hz, 1H); 5.73-5.81 (m, 2H); 6.16 (dd, J1 
= 17.3 Hz, J2 = 10.7 Hz, 1H); 7.14 (m, 1H); 7.21-7.30 (m, 
2H); 7.36-7.71 (m, 2H). 
13
C NMR (75 MHz, CDCl3):   
22.3 (CH3); 22.8 (CH3); 25.0 (CH2); 26.7 (CH3); 31.4 
(CH); 35.2 (CH2); 41.4 (CH2); 44.3 (CH); 47.2 (CH2); 57.9 
(C); 75.3 (CH2); 77.4 (CH); 90.6 (CH); 93.5 (C); 113.3 
(CH2); 125.2 (CH); 126.6 (CH); 127.0 (2 CH); 127.5 (2 
CH); 130.3 (CH); 138.7 (CH); 144.4 (C). IR (film):  3060, 
1730, 720, 695 cm
-1
.  HRMS calcd for C24H34NO2 [M + 
H]
+
 368.2584, found 368.2586. 
(2S,4aS,7R,8aR)-3-benzyl-4,4,7-trimethyl-2-((S)-2-vinyl-
2,5-dihydrofuran-2-yl)octahydro-2H-
benzo[e][1,3]oxazine (8a). This compound was obtained 
from 4a (1.2 g) and catalyst 6, and purified by flash 
chromatography (hexanes/ ethyl acetate 45:1). Yield: 0.57 
g, 51%.  Colorless oil. [α]D
25
 = +1.9 (c = 0.5, ethyl acetate).
 
1
H NMR (300 MHz, CDCl3):   0.86-1.03 (m, 2H); 0.88 (s, 
3H); 0.92 (d, J = 6.5 Hz, 3H); 1.18 (m, 1H); 1.26 (s, 3H); 
1.29-1.67 (m, 4H); 1.93 (m, 1H); 3.51 (td, J1 = 10.7 Hz, J2 
= 3.5 Hz, 1H); 3.96 (d, J = 18.6 Hz, 1H); 4.37-4.53 (m, 
2H); 4.42 (d, J = 18.6 Hz, 1H); 4.74 (s, 1H);  4.99 (dd, J1 = 
10.6 Hz, J2 = 1.7 Hz, 1H); 5.16 (dd, J1 = 17.3 Hz, J2 = 1.7 
Hz, 1H); 5.63 (m, 1H); 5.79 (m, 1H); 6.07 (dd, J1 = 17.3 
Hz, J2 = 10.6 Hz, 1H); 7.13 (m, 1H); 7.20-7.25 (m, 2H); 
7.32-7.61 (m, 2H). 
13
C NMR (75 MHz, CDCl3):   22.0 
(CH3); 22.2 (CH3); 24.9 (CH2); 26.6 (CH3); 31.4 (CH); 
35.1 (CH2); 41.4 (CH2); 44.8 (CH); 46.9 (CH2); 58.2 (C); 
74.8 (CH2); 77.8 (CH); 90.5 (CH); 94.0 (C); 113.0 (CH2); 
125.2 (CH); 126.7 (CH); 127.0 (2 CH); 127.3 (2 CH); 
129.4 (CH); 139.9 (CH); 144.2 (C). IR (film): 3060, 1600, 
720, 700 cm
-1
.  HRMS calcd for C24H34NO2 [M + H]
+
 
368.2584, found 368.2589. 
(2S,4aS,7R,8aR)-3-benzyl-4,4,7-trimethyl-2-((R)-4-
methyl-2-vinyl-2,5-dihydrofuran-2-yl)octahydro-2H-
benzo[e][1,3]oxazine (7b). This compound was obtained 
from 4b (1.2 g) and catalyst 6, and purified by flash 
chromatography (hexanes/ ethyl acetate 50:1). Yield: 0.15 
g, 13%.  Colorless oil. [α]D
25
 = -20.1 (c = 0.5, CH2Cl2).
 1
H 
NMR (300 MHz, CDCl3):   0.82-1.06 (m, 2H); 0.89 (s, 
3H); 0.93 (d,  J = 6.5 Hz, 3H); 1.12 (m, 1H); 1.27 (s, 3H); 
1.40-1.76 (m, 5H); 1.59 (d,  J = 1.1 Hz, 3H); 1.93 (m, 1H); 
3.49 (td, J1 = 10.4 Hz, J2 = 3.8 Hz, 1H); 3.88 (d, J =18.4 Hz, 
1H); 4.22-4.34 (m, 2H); 4.61 (d, J = 18.4 Hz, 1H); 4.73 (s, 
1H);  4.94 (dd, J1 = 10.7 Hz, J2 = 1.8 Hz, 1H); 5.03 (dd, J1 
= 17.3 Hz, J2 = 1.8 Hz, 1H); 5.36 (m, 1H); 6.13 (dd, J1 = 
17.3 Hz, J2 = 10.7 Hz, 1H); 7.11 (m, 1H); 7.17-7.26 (m, 
2H); 7.30-7.43 (m, 2H). 
13
C NMR (75 MHz, CDCl3):   
12.3 (CH3); 22.3 (CH3); 22.6 (CH3); 25.0 (CH2); 26.7 
(CH3); 31.5 (CH); 35.2 (CH2); 41.4 (CH2); 44.5 (CH); 47.2 
(CH2); 57.9 (C); 77.4 (CH); 77.7 (CH2); 90.8 (CH); 93.9 
(C); 112.5 (CH2); 124.0 (CH); 125.2 (CH); 127.1 (2 CH); 
127.5 (2 CH); 139.4 (C); 144.5 (CH); 158.7 (C). IR (film): 
 13 
3060, 1450, 720, 695 cm
-1
. HRMS calcd for C25H36NO2 [M 
+ H]
+
 382.2741, found 382.2750. 
(2S,4aS,7R,8aR)-3-benzyl-4,4,7-trimethyl-2-((S)-4-
methyl-2-vinyl-2,5-dihydrofuran-2-yl)octahydro-2H-
benzo[e][1,3]oxazine (8b). This compound was obtained 
from 4b (1.2 g) and catalyst 6, and purified by flash 
chromatography (hexanes/ ethyl acetate 50:1). Yield: 0.19 
g, 17%.  Colorless oil. [α]D
25
 = -2.8 (c = 0.5, CH2Cl2).
 1
H 
NMR (300 MHz, CDCl3):   0.82-1.05 (m, 2H); 0.89 (s, 
3H); 0.92 (d, J = 6.5 Hz, 3H); 1.22 (m, 1H); 1.27 (s, 3H); 
1.28 (s, 3H); 1.40-1.78 (m, 4H); 1.93 (m, 1H); 3.49 (td, J1= 
10.5 Hz, J2 = 3.9 Hz, 1H); 3.92 (d, J = 18.7 Hz, 1H); 4.07 
(d, J = 12.3 Hz, 1H); 4.31 (d, J = 12.3 Hz, 1H); 4.56 (d, J = 
18.7 Hz, 1H); 4.71 (s, 1H);  4.98 (dd, J1 = 10.6 Hz, J2 = 1.7 
Hz, 1H); 5.16 (dd, J1 = 17.3 Hz, J2 = 1.7 Hz, 1H); 5.36 (m, 
1H); 6.05 (dd, J1 = 17.2 Hz, J2 = 10.6 Hz, 1H); 7.08 (m, 
1H); 7.14-7.24 (m, 2H); 7.26-7.45 (m, 2H). 
13
C NMR (75 
MHz, CDCl3):   12.0 (CH3); 22.3 (CH3); 22.5 (CH3); 25.0 
(CH2); 26.3 (CH3); 31.5 (CH); 35.2 (CH2); 41.4 (CH2); 
44.6 (CH); 46.6 (CH2); 58.12 (C); 77.2 (CH2); 77.9 (CH);  
89.9 (CH); 94.5 (C); 112.3 (CH2); 123.6 (CH); 125.0 (CH); 
126.8 (2 CH); 127.3 (2 CH); 135.9 (C); 141.0 (CH); 144.6 
(C). IR (film): 3020, 1600, 720, 695 cm
-1
. HRMS calcd for 
C25H36NO2 [M + H]
+
 382.2741, found 382.2744. 
(2S,4aS,7R,8aR)-3-benzyl-4,4,7-trimethyl-2-((R)-3-
methyl-2-(prop-1-en-2-yl)-2,5-dihydrofuran-2-
yl)octahydro-2H-benzo[e][1,3]oxazine (7c). This 
compound was obtained from 4c (1.2 g) and catalyst 6, and 
purified by flash chromatography (hexanes/ ethyl acetate 
45:1). Yield: 1.03 g, 92%.  White solid. Mp 160-162 ºC 
(from hexane). [α]D
25
 = -64.2 (c = 1, CHCl3).
 1
H NMR (300 
MHz, CDCl3):   0.83-101 (m, 2H); 0.84 (s, 3H); 0.92 (d, J 
= 6.5 Hz, 3H); 1.13 (m, 1H); 1.29 (s, 3H); 1.39-1.70 (m, 
4H); 1.72 (s, 3H); 1.79 (d, J = 1.7 Hz, 3H); 1.86 (m, 1H); 
3.46 (td, J1 = 10.5 Hz, J2 = 4.0 Hz, 1H); 3.84 (d, J = 17.7 
Hz, 1H); 4.44 (m, 1H); 4.57 (m, 1H); 4.82 (d, J = 1.7 Hz, 
1H); 4.98 (d, J = 17.7 Hz, 1H); 4.99 (d, J = 1.7 Hz, 1H); 
5.06 (s, 1H);  5.48 (m, 1H); 7.08 (m, 1H); 7.17-7.25 (m, 
2H); 7.35-7.37 (m, 2H). 
13
C NMR (75 MHz, CDCl3):   
13.0 (CH3); 20.0 (CH3); 22.2 (2 CH3); 24.9 (CH2); 27.2 
(CH3); 31.5 (CH); 35.1 (CH2); 41.3 (CH2); 43.9 (CH); 47.6 
(CH2); 58.4 (C); 74.5 (CH2); 77.9 (CH); 85.9 (CH); 96.0 
(C); 111.7 (CH2); 121.3 (CH); 124.9 (CH); 127.1 (2 CH); 
127.3 (2 CH); 138.9 (C); 145.0 (C); 145.5 (C). IR (Nujol 
dispersion): 3060, 1640, 720, 695 cm
-1
.  HRMS calcd for 
C26H38NO2 [M + H]
+
 396.2897, found 396.2906. 
(2S,4aS,7R,8aR)-3-benzyl-2-((R)-3,4-dimethyl-2-(prop-
1-en-2-yl)-2,5-dihydrofuran-2-yl)-4,4,7-
trimethyloctahydro-2H-benzo[e][1,3]oxazine (7d). This 
compound was obtained from 4d (1.2 g) and catalyst 6, 
and purified by flash chromatography (hexanes/ ethyl 
acetate 60:1). Yield: 0.82 g, 73%.  Colorless oil. [α]D
25
 = -
74.7 (c = 1, CH2Cl2).
 1
H NMR (300 MHz, CDCl3):   0.83 
(s, 3H); 0.84-1.06 (m, 2H); 0.92 (d, J = 6.5 Hz, 3H); 1.14 
(m, 1H); 1.28 (s, 3H); 1.39-1.72 (m, 4H); 1.56 (s, 3H); 
1.66 (d, J = 1.0 Hz, 3H); 1.71 (s, 3H); 1.84 (m, 1H); 3.43 
(td, J1 = 10.5 Hz, J2 = 4.0 Hz, 1H); 3.86 (d, J = 17.5 Hz, 
1H); 4.32-4.45 (m, 2H); 4.78 (m, 1H); 4.92 (d, 1H, J = 
17.5 Hz); 4.95 (s, 1H); 5.03 (s, 1H);  7.07 (m, 1H); 7.16-
7.21 (m, 2H); 7.35-7.37 (m, 2H). 
13
C NMR (75 MHz, 
CDCl3):   10.1 (CH3); 10.5 (CH3); 20.1 (CH3); 22.1 
(CH3); 22.3 (CH3); 25.0 (CH2); 27.2 (CH3); 31.5 (CH); 
35.2 (CH2); 41.4 (CH2); 44.1 (CH); 47.8 (CH2); 58.5 (C); 
77.8 (CH); 78.4 (CH2); 86.4 (CH); 97.4 (C); 111.2 (CH2); 
124.9 (CH); 127.1 (2 CH); 127.2 (2 CH); 128.2 (C); 129.9 
(C); 145.5 (C); 145.6 (C). IR (film): 3020, 1600, 720, 695 
cm
-1
. HRMS calcd for C27H40NO2 [M + H]
+
 410.3054, 
found 410.3058. 
(2S,4aS,7R,8aR)-3-benzyl-2-((S)-3,4-dimethyl-2-(prop-
1-en-2-yl)-2,5-dihydrofuran-2-yl)-4,4,7-
trimethyloctahydro-2H-benzo[e][1,3]oxazine (8d). This 
compound was obtained from 4d (1.2 g) and catalyst 6, 
and purified by flash chromatography (hexanes/ ethyl 
acetate 60:1). Yield: 0.15 g, 13%. White solid. Mp 128-
130 ºC (from hexane). [α]D
25
 = +64.3 (c = 1.5, CHCl3).
 1
H 
NMR (300 MHz, CDCl3):   0.83-1.03 (m, 2H); 0.89 (s, 
3H); 0.90 (d, J = 6.6 Hz, 3H); 0.92 (s, 3H); 1.21 (m, 1H); 
1.34 (s, 3H); 1.42-1.74 (m, 4H); 1.65 (s, 3H); 1.67 (s, 3H); 
1.93 (m, 1H); 3.50 (td, J1 = 10.5 Hz, J2 = 3.9 Hz, 1H); 3.86 
(d, J = 19.0 Hz, 1H); 3.91 (m, 1H); 4.26 (m, 1H); 4.77 (d, J 
= 19.0 Hz, 1H); 4.89-4.90 (m, 2H); 5.14 (s, 1H);  7.05 (m, 
1H); 7.15-7.21 (m, 2H); 7.25-7.27 (m, 2H). 
13
C NMR (75 
MHz, CDCl3):   9.3 (CH3); 10.3 (CH3); 19.7 (CH3); 22.2 
(CH3); 22.7 (CH3); 25.0 (CH2); 26.2 (CH3); 31.5 (CH); 
35.2 (CH2); 41.4 (CH2); 43.8 (CH); 46.2 (CH2); 58.5 (C); 
78.1 (CH); 78.3 (CH2); 86.2 (CH); 97.4 (C); 109.6 (CH2); 
124.8 (CH); 126.1 (2 CH); 127.2 (2 CH); 128.6 (C); 128.8 
(C); 145.2 (C); 148.5 (C). IR (Nujol dispersion): 3085, 
1600, 720, 695 cm
-1
. HRMS calcd for C27H40NO2 [M + H]
+
 
410.3054, found 410.3062. 
(2S,4aS,7R,8aR)-2-((R)-2-allyl-3,6-dihydro-2H-pyran-2-
yl)-3-benzyl-4,4,7-trimethyloctahydro-2H-
benzo[e][1,3]oxazine (7e). This compound was obtained 
from 4e (1.2 g) and catalyst 5, and purified by flash 
chromatography (hexanes/ ethyl acetate 60:1). Yield: 0.67 
g, 60%. Colorless oil. [α]D
25
 = +27.1 (c = 2.0, CH2Cl2).
 1
H 
NMR (300 MHz, CDCl3):  0.87-1.04 (m, 2H); 0.92 (d, J = 
6.4 Hz, 3H); 0.93 (s, 3H); 1.24 (m, 1H); 1.29 (s, 3H); 1.47 
(m, 1H); 1.55-1.78 (m, 3H);  1.81-2.01 (m, 2H); 2.25 (m, 
1H); 2.40 (m, 1H); 2.55 (m, 1H); 3.46 (td, J1 = 10.6 Hz, J2 
= 3.8 Hz, 1H); 3.86-3.99 (m, 2H); 4.12 (m, 1H); 4.38 (s, 
1H); 5.02-5.08 (m, 3H);  5.62 (m, 1H); 5.70 (m, 1H); 6.12 
(m, 1H); 7.13 (m, 1H); 7.24-7.29 (m, 2H); 7.40-7.43 (m, 
2H). 
13
C NMR (75 MHz, CDCl3):   22.3 (2 CH3); 25.0 
(CH2); 27.0 (CH3); 28.5 (CH2); 31.6 (CH); 35.2 (CH2); 
35.4 (CH2); 41.5 (CH2); 44.1 (CH); 47.9 (CH2); 58.6 (C); 
60.7 (CH2); 76.4 (C); 78.3 (CH); 89.4 (CH); 118.0 (CH2); 
123.1 (CH); 124.9 (CH); 125.2 (CH); 126.8 (2 CH); 127.8 
(2 CH); 134.9 (CH); 145.2 (C). IR (film): 3060, 1740, 
1640, 730, 670 cm
-1
. HRMS calcd for C26H38NO2 [M + H]
+
 
396.2897, found 396.2893. 
(2S,4aS,7R,8aR)-2-((S)-2-allyl-3,6-dihydro-2H-pyran-2-
yl)-3-benzyl-4,4,7-trimethyloctahydro-2H-
benzo[e][1,3]oxazine (8e). This compound was obtained 
from 4e (1.2 g) and catalyst 6, and purified by flash 
chromatography (hexanes/ ethyl acetate 60:1). Yield: 0.71 
g, 63%. White solid. Mp 76-78 ºC (from pentane). [α]D
25
 = 
-18.7 (c = 1.5, CH2Cl2).
 1
H NMR (300 MHz, CDCl3):  
0.89-1.06 (m, 2H); 94 (d, J = 6.5 Hz, 3H); 0.99 (s, 3H); 
1.23 (m, 1H); 1.27 (s, 3H); 1.40-1.75 (m, 5H);  1.95 (m, 
1H); 2.39 (dd, J1 = 13.4 Hz, J2 = 6.9 Hz, 1H); 2.51 (dd, J1 = 
17.4 Hz, J2 = 7.6 Hz, 1H); 2.70 (m, 1H); 3.49 (td, J1 = 10.8 
Hz, J2 = 3.8 Hz, 1H); 3.89 (d, J = 18.1 Hz, 1H); 3.95 (m, 
1H); 4.09 (m, 1H); 4.55 (s, 1H); 4.68 (d,  J = 18.1 Hz, 1H); 
5.12 (m, 2H);  5.48 (m, 1H); 5.55 (m, 1H); 5.89 (m, 1H); 
7.14 (m, 1H); 7.20-7.29 (m, 2H); 7.31-7.42 (m, 2H). 
13
C 
NMR (75 MHz, CDCl3):  22.3 (CH3); 23.0 (CH3); 25.0 
(CH2); 27.0 (CH3); 27.4 (CH2); 31.5 (CH); 35.2 (CH2); 
37.0 (CH2); 41.4 (CH2); 44.5 (CH); 47.5 (CH2); 58.8 (C); 
60.5 (CH2); 76.6 (C); 78.0 (CH); 88.9 (CH); 117.8 (CH2); 
122.2 (CH); 124.4 (CH); 125.1 (CH); 127.0 (2 CH); 127.6 
(2 CH); 134.6 (CH); 144.6 (C). IR (film): 3060, 1640, 720, 
670 cm
-1
. HRMS calcd for C26H38NO2 [M + H]
+
 396.2897, 
found 396.2895. 
(2S,4aS,7R,8aR)-3-benzyl-4,4,7-trimethyl-2-((R)-4-
methyl-2-(2-methylallyl)-3,6-dihydro-2H-pyran-2-
yl)octahydro-2H-benzo[e][1,3]oxazine (7f). This 
compound was obtained from 4f (1.2 g) and catalyst 5, and 
purified by flash chromatography (hexanes/ ethyl acetate 
50:1). Yield: 0.82 g, 73%. Colorless oil. [α]D
25
 = +21.6 (c = 
1.8, CH2Cl2).
 1
H NMR (300 MHz, CDCl3):  0.78-0.96 (m, 
2H); 0.85 (d, J = 6.5 Hz, 3H); 0.91 (s, 3H); 1.08 (m, 1H); 
1.16 (s, 3H); 1.28-1.65 (m, 5H); 1.52 (s, 3H); 1.70 (s, 3H); 
1.82 (m, 1H); 2.16 (d, J = 13.7 Hz, 1H); 2.29 (d, J = 13.7 
Hz, 1H); 2.45 (m, 1H); 3.38 (td, J1 = 10.4 Hz, J2 = 3.9 Hz, 
1H); 3.81-3.91 (m, 2H); 4.00 (m, 1H); 4.50 (s, 1H); 4.64 
(m, 1H); 4.78-4.80 (m, 2H);  5.14 (m, 1H); 7.05 (m, 1H); 
7.14-7.23 (m, 2H); 7.27-7.43 (m, 2H). 
13
C NMR (75 MHz, 
CDCl3):  20.7 (CH3); 22.2 (CH3); 23.0 (CH3); 24.7 (CH3); 
25.2 (CH2); 27.2 (CH3); 31.5 (CH); 34.0 (CH2); 35.2 
(CH2); 39.4 (CH2); 41.6 (CH2); 46.0 (CH); 48.0 (CH2); 
58.9 (C); 60.8 (CH2); 77.2 (C); 77.3 (CH); 89.7 (CH); 
 14 
114.4 (CH2); 117.8 (CH); 125.1 (CH); 127.2 (2 CH); 127.5 
(2 CH); 130.7 (C); 142.9 (C); 145.0 (C). IR (film): 3060, 
1640, 730, 700 cm
-1
. HRMS calcd for C28H42NO2 [M + H]
+
 
424.3210, found 424.3207. 
(2S,4aS,7R,8aR)-3-benzyl-4,4,7-trimethyl-2-((S)-4-
methyl-2-(2-methylallyl)-3,6-dihydro-2H-pyran-2-
yl)octahydro-2H-benzo[e][1,3]oxazine (8f). This 
compound was obtained from 4f (1.2 g) and catalyst 6, and 
purified by flash chromatography (hexanes/ ethyl acetate 
50:1). Yield: 0.66 g, 59%. White solid. Mp 93-95 ºC (from 
hexane). [α]D
25
 = -52.0 (c = 2.0, CH2Cl2).
 1
H NMR (300 
MHz, CDCl3):  0.83-1.02 (m, 2H); 0.93 (d, J = 6.4 Hz, 
3H); 0.98 (s, 3H); 1.23 (m, 1H); 1.25 (s, 3H); 1.41-1.74 (m, 
5H); 1.52 (s, 3H); 1.78 (s, 3H); 1.90 (m, 1H); 2.31 (d, 1H, 
J = 13.2 Hz); 2.55 (d, 1H, J = 13.2 Hz); 2.62 (m, 1H); 3.48 
(td, J1 = 10.6 Hz, J2 = 3.9 Hz, 1H); 3.89 (d, J = 17.9 Hz, 
1H); 3.94 (m, 1H); 4.06 (m, 1H); 4.62 (s, 1H); 4.78 (d, J = 
0.9 Hz, 1H); 4.84 (d, J = 17.9 Hz, 1H); 4.87 (d, J = 0.9 Hz, 
1H); 5.23 (m, 1H); 7.11 (m, 1H); 7.19-7.28 (m, 2H); 7.31-
7.42 (m, 2H). 
13
C NMR (75 MHz, CDCl3): 22.2 (CH3); 
22.9 (CH3); 23.0 (CH3); 24.5 (CH3); 25.2 (CH2); 27.2 
(CH3); 31.7 (CH); 32.8 (CH2); 35.4 (CH2); 40.1 (CH2); 
41.6 (CH2); 44.9 (CH); 47.7 (CH2); 58.9 (C); 60.9 (CH2); 
77.6 (C); 77.7 (CH); 88.2 (CH); 114.6 (CH2); 117.9 (CH); 
125.1 (CH); 127.2 (2 CH); 127.5 (2 CH); 129.7 (C); 143.0 
(C); 144.9 (C).IR (nujol dispersion): 3060, 1640, 730, 700 
cm
-1
. HRMS calcd for C28H42NO2 [M + H]
+
 424.3210, 
found 424.3210. 
(2S,4aS,7R,8aR)-3-benzyl-2-((R)-4,5-dimethyl-2-(2-
methylallyl)-3,6-dihydro-2H-pyran-2-yl)-4,4,7-
trimethyloctahydro-2H-benzo[e][1,3]oxazine (7g). This 
compound was obtained from 4g (1.2 g) and catalyst 6, and 
purified by flash chromatography (hexanes/ ethyl acetate 
60:1). Yield: 0.68 g, 60%. Colorless oil. [α]D
25
 = +17.0 (c = 
1.0, CH2Cl2).
 1
H NMR (300 MHz, CDCl3):  0.84-1.05 (m, 
2H); 0,93(d, J = 6.5 Hz, 3H); 0.99 (s, 3H); 1.20 (m, 1H); 
1.23 (s, 3H); 1.35-1.73 (m, 5H); 1.40 (s, 3H); 1.54 (s, 3H); 
1.76 (s, 3H); 1.94 (m, 1H); 2.22 (d, J = 13.8 Hz, 1H); 2.35 
(d, J = 13.8 Hz, 1H); 2.52 ( m, 1H); 3.45 (td, J1 = 10.4 Hz, 
J2 = 4.1 Hz, 1H); 3.76 (m, 1H); 3.86 (m, 1); 3.94 (d, J = 
17.8 Hz, 1H); 4.55 (s, 1H); 4.74 (d, J = 17.8 Hz, 1H); 4.84 
(s, 2H); 7.12 (m, 1H); 7.17-7.28 (m, 2H); 7.38-7.44 (m, 
2H) 
13
C NMR (75 MHz, CDCl3):   13.5 (CH3); 18.4 
(CH3); 20.8 (CH3); 22.2 (CH3); 24.7 (CH3); 25.2 (CH2); 
27.3 (CH3); 31.6 (CH); 34.9 (CH2); 35.3 (CH2); 39.5 
(CH2); 41.7 (CH2); 46.0 (CH); 48.1 (CH2); 58.9 (C); 64.7 
(CH2); 77.3 (CH); 77.8 (C); 89.6 (CH); 114.3 CH2); 122.2 
(C); 122.7 (C); 125.1 (CH); 127.3 (2 CH); 127.5 (2 CH); 
143.1 (C); 145.1 (C). IR (film): 3065, 1635, 735, 700 cm
-1
. 
HRMS calcd for C29H44NO2 [M + H]
+
 438.3367, found 
438.3369 
(2S,4aS,7R,8aR)-3-benzyl-2-((S)-4,5-dimethyl-2-(2-
methylallyl)-3,6-dihydro-2H-pyran-2-yl)-4,4,7-
trimethyloctahydro-2H-benzo[e][1,3]oxazine (8g). This 
compound was obtained from 4g (1.2 g) and catalyst 6, and 
purified by flash chromatography (hexanes/ ethyl acetate 
60:1). Yield: 0.25 g, 22%. White solid. Mp 87-89 ºC (from 
pentane). [α]D
25
= -61.5 (c = 2.0, CH2Cl2). 
1
H NMR (300 
MHz, CDCl3):  0.88-1.03 (m, 2H); 0.93 (d, J = 6.5 Hz, 
3H); 0.95 (s, 3H); 1.25 (s, 3H); 1.35 (s, 3H); 1.43-1.72 (m, 
5H); 1.47 (s, 3H); 1.77 (s, 3H); 1.90 (m, 1H); 2.28 (d, J = 
13.2 Hz, 1H); 2.53 (d, J=13.2 Hz, 1H); 2.59 (m, 1H); 3.47 
(td, J1 = 10.5 Hz, J2 = 3.9 Hz, 1H); 3.73 (m, 1H); 3.89 (d, J 
= 17.9 Hz, 1H); 3.90 (m, 1H); 4.63 (s, 1H); 4.77 (m, 1H); 
4.82 (d, J = 17.9 Hz, 1H);  4.88 (m, 1H); 7.09 (m, 1H); 
7.20-7.25 (m, 2H); 7.26-7.39 (m, 2H). 
13
C NMR (75 MHz, 
CDCl3):  13.5 (CH3); 18.4 (CH3); 20.8 (CH3); 22.2 (CH3); 
24.7 (CH3); 25.2 (CH2); 27.3 (CH3); 31.6 (CH); 34.9 
(CH2); 35.3 (CH2); 39.5 (CH2); 41.7 (CH2); 46.0 (CH); 
48.1 (CH2); 58.9 (C); 64.7 (CH2); 77.3 (CH); 77.8 (C); 
89.6 (CH); 114.3 (CH2); 122.2 (C); 122.7 (C); 125.1 ( CH); 
127.3 (2 CH); 127.5 (2 CH); 143.1 (C); 145.1 (C). IR 
(film): 3060, 1635, 725, 695 cm
-1
. HRMS calcd for 
C29H44NO2 [M + H]
+
 438.3367, found 438.3368. 
(2S,4aS,7R,8aR)-3-benzyl-2-((R)-2-ethyl-2,5-
dihydrofuran-2-yl)-4,4,7-trimethyloctahydro-2H-
benzo[e][1,3]oxazine (14). This compound was obtained 
from 13 (2.0 g) and catalyst 5, and purified by flash 
chromatography (hexanes/ ethyl acetate 45:1). Yield: 1.63 
g, 88 %. Colorless oil. [α]D
25
= +6.2 (c = 0.8, CH2Cl2). 
1
H 
NMR (300 MHz, CDCl3):  0.82 (t, J = 7.4 Hz, 3H); 0.84-
1.00 (m, 2H); 0.87 (s, 3H); 0.92 (d, J = 6.5 Hz, 3H); 1.13 
(m,1H); 1.28 (s, 3H); 1.35-1.58 (m, 2H); 1.60-1.73 (m, 
4H); 1.86 (m, 1H); 3.44 (td, J1 = 10.6 Hz, J2 = 3.9 Hz, 1H); 
3.93 (d, J=18.4 Hz, 1H); 4.48-4.51 (m, 2H); 4.66 (s, 1H); 
4.78 (d, J = 18.4 Hz, 1H);  5.65 (m, 1H); 5.84 (m, 1H); 
7.11 (m, 1H); 7.22-7.27 (m, 2H); 7.41-7.43 (m, 2H). 
13
C 
NMR (75 MHz, CDCl3):  8.27 (CH3); 22.3 (CH3); 22.7 
(CH3); 24.9 (CH2); 26.8 (CH3); 29.7 (CH2); 31.5 (CH); 
35.2 (CH2); 41.3 (CH2); 43.8 (CH); 47.3 (CH2); 57.9 (C); 
76.6 (CH2); 77.6 (CH); 89.9 (CH); 94.5 (C); 125.2 (CH); 
126.7 (2 CH); 127.1 (CH); 127.6 (2 CH); 130.7 (CH); 
144.9 (C). IR (film): 3058, 1605, 722, 695 cm
-1
. HRMS 
calcd for C24H36NO2 [M + H]
+
 370.2741, found 370.2750  
(3R,4aR,5aS,6R,11aS)-3,11,11-trimethyl-6-vinyl-
2,3,4,4a,5a,6,11,11a-octahydro-1H,9H-
benzo[e]pyrido[2,1-b][1,3]oxazin-6-ol (22a). This 
compound was obtained from 19a (1.0 g) and catalyst 5, 
and purified by flash chromatography (hexanes/ ethyl 
acetate 20:1). Yield: 0.17 g, 19 %. White solid. Mp 136-
138 ºC (from hexane). [α]D
25
= -112.2 (c = 1.2, CH2Cl2).
 1
H 
NMR (300 MHz, CDCl3):   0.90 (d, J=6.4 Hz, 3H); 0.92-
1.25 (m, 3H); 1.18 (s, 3H); 1.22 (s, 3H); 1.46 (m, 1H); 
1.56-1.63 (m, 2H); 1.71 (m, 1H); 1.89 (m, 1H); 2.70 (broad, 
1H); 3.26 (m, 1H); 3.40 (td, J1 = 10.7 Hz, J2 = 3.9 Hz, 1H); 
3.48 (m, 1H); 4.52 (s, 1H); 5.20 (dd, J1 = 10.7 Hz, J2 = 1.7 
Hz, 1H); 5.46 (dd, J1 = 17.3 Hz, J2 = 1.7 Hz, 1H); 5.69 (d, 
J = 9.9 Hz, 1H); 5.89 (ddd, J1 = 9.9 Hz, J2 = 4.2 Hz , J3 = 
2.5 Hz, 1H); 6.06 (dd, J1 = 17.3 Hz, J2 = 10.7 Hz, 1H). 
13
C 
NMR (75 MHz, CDCl3):  21.0 (CH3); 22.0 (CH3); 24.8 
(CH2); 25.8 (CH3); 31.2 (CH); 34.8 (CH2); 40.8 (CH2); 
41.3 (CH2); 43.4 (CH); 56.0 (C); 69.7 (C); 76.7 (CH); 87.7 
(CH); 113.4 (CH2); 126.6 (CH); 127.7 (CH); 139.2 (CH). 
IR (nujol dispersion): 3320 (broad), 3095, 1655, 830, 730 
cm
-1
. HRMS calcd for C17H28NO2 [M + H]
+
 278.2115, 
found 278.2118. 
(3R,4aR,5aS,6S,11aS)-3,11,11-trimethyl-6-vinyl-
2,3,4,4a,5a,6,11,11a-octahydro-1H,9H-
benzo[e]pyrido[2,1-b][1,3]oxazin-6-ol (23a). This 
compound was obtained from 19a (1.0 g) and catalyst 6, 
and purified by flash chromatography (hexanes/ ethyl 
acetate 20:1). Yield: 0.24 g, 26 %. Colorless oil. [α]D
25
= -
113.3 (c = 1.5, CH2Cl2).
 1
H NMR (300 MHz, CDCl3):  
0.90-1.15 (m, 3H); 0.92 (d, J = 6.6 Hz, 3H); 1.16 (s, 3H); 
1.17 (s, 3H); 1.56 (m, 1H); 1.57-1.73 (m, 3H); 1.90 (m, 
1H); 3.22 (m, 1H); 3.28 (s, 1H); 3.40 (m, 1H); 3.50 (td, J1 
= 10.3 Hz, J2 = 3.7 Hz, 1H); 4.55 (s, 1H); 5.13 (dd, J1 = 
10.6 Hz, J2 = 1.7 Hz, 1H); 5.36 (dd, J1 = 17.3 Hz, J2 = 1.7 
Hz, 1H); 5.52 (d, J= 10.0 Hz, 1H);  5.78 (m, 1H); 5.93 (dd, 
J1 = 17.3 Hz, J2 = 10.6 Hz, 1H). 
13
C NMR (75 MHz, 
CDCl3):  20.9 (CH3); 22.0 (CH3); 24.6 (CH2); 25.7 (CH3); 
31.1 (CH); 34.7 (CH2); 40.8 (CH2); 41.3 (CH2); 43.1 (CH); 
56.0 (C); 70.9 (C); 76.7 (CH); 85.7 (CH); 113.5 (CH2); 
124.8 (HC); 127.1 (HC); 140.7 (HC). IR (film): 3545 
(broad), 3040, 725 cm
-1
. HRMS calcd for C17H28NO2 [M + 
H]
+
 278.2115, found 278.2113. 
(3R,4aR,5aS,6R,11aS)-6-methoxy-3,11,11-trimethyl-6-
vinyl-2,3,4,4a,5a,6,11,11a-octahydro-1H,9H-
benzo[e]pyrido[2,1-b][1,3]oxazine (24a). This compound 
was obtained from 20a (1.0 g) and catalyst 5, and purified 
by flash chromatography (hexanes/ ethyl acetate 20:1). 
Yield: 0.55 g, 60%. Colorless oil. [α]D
25
= -132.3 (c = 0.5, 
CH2Cl2).
 1
H NMR (300 MHz, CDCl3):  0.89 (d, J = 6.5 
Hz, 3H); 0.95-1.01 (m, 2H); 1.05 (m, 1H); 1.21 (s, 3H); 
1.26 (s, 3H); 1.42-1.60 (m, 3H); 1.69 (m, 1H); 1.84 (m, 
1H); 3.24 (s, 3H); 3.33-3.53 (m, 3H); 4.65 (s, 1H); 5.28 (dd, 
J1 = 10.8 Hz, J2 = 1.2 Hz, 1H); 5.30 (dd, J1 = 17.8 Hz, J2 = 
1.2 Hz, 1H); 5.82 (m, 1H); 5.83 (dd, J1 = 17.8 Hz, J2 = 10.8 
Hz, 1H), 6.10 (m, 1H). 
13
C NMR (75 MHz, CDCl3):  21.0 
(CH3); 22.1 (CH3); 25.0 (CH2); 26.0 (CH3); 31.4 (CH); 
35.0 (CH2); 41.1 (CH2); 41.9 (N-CH2); 43.5 (CH); 50.8 
 15 
(CH3); 56.0 (C); 75.1 (C); 76.9 (CH); 86.7 (CH); 115.5 
(CH2); 121.5 (HC); 131.0 (HC); 138.7 (HC). IR (film): 
3085, 1650, 81, 730 cm
-1
. HRMS calcd for C18H30NO2 [M 
+ H]
+
 292.2271, found 292.2273 
(3R,4aR,5aS,6S,11aS)-6-methoxy-3,11,11-trimethyl-6-
vinyl-2,3,4,4a,5a,6,11,11a-octahydro-1H,9H-
benzo[e]pyrido[2,1-b][1,3]oxazine (25a). This compound 
was obtained from 20a (1.0 g) and catalyst 6, and purified 
by flash chromatography (hexanes/ ethyl acetate 20:1). 
Yield: 0.58 g, 64%. White solid. Mp 77-79 ºC (from 
pentane). [α]D
25
= -129.9 (c = 1.0, CH2Cl2).
 1
H NMR (300 
MHz, CDCl3):  0.86-1.02 (m, 2H); 0.91 (d, J = 6.5 Hz, 
3H); 1.13 (m, 1H); 1.15 (s, 3H); 1.20 (s, 3H); 1.50 (m, 
1H); 1.54-1.72 (m, 2H); 1.98 (m, 1H); 3.22 (m, 1H); 3.32 
(s, 3H); 3.43-3.51 (m, 2H); 4.75 (s, 1H); 5.23 (dd, J1 = 10.7 
Hz, J2 = 1.4 Hz, 1H), 5.28 (dd, J1 = 17.7 Hz, J2 = 1.4 Hz, 
1H); 5.60 (d, J= 10.2 Hz, 1H); 5.81 (m, 1H); 5.85 (dd, J1 = 
17.7 Hz, J2 = 10.7 Hz, 1H). 
13
C NMR (75 MHz, CDCl3):  
21.5 (CH3); 22.2 (CH3); 25.0 (CH2); 26.1 (CH3); 31.5 
(CH); 35.0 (CH2); 41.3 (CH2); 41.9 (CH2); 43.1 (CH); 50.6 
(CH3); 56.3 (C); 76.5 (C) 77.1 (CH); 84.5 (CH); 115.8 
(CH2); 124.0 (CH); 126.1 (CH); 139.7 (CH). IR (film): 
3085, 1664, 723, 656 cm
-1
. HRMS calcd for C18H30NO2 [M 
+ H]
+
 292.2271, found 292.2271 
(3R,4aR,5aS,6R,11aS)-6-methoxy-3,7,11,11-
tetramethyl-6-(prop-1-en-2-yl)-2,3,4,4a,5a,6,11,11a-
octahydro-1H,9H-benzo[e]pyrido[2,1-b][1,3]oxazine 
(24b). This compound was obtained from 20b (1.0 g) and 
catalyst 6, and purified by flash chromatography inCH2Cl2. 
Yield: 0.69 g, 75%. Colorless oil. [α]D
25
= -76.4 (c = 1.0, 
CH2Cl2).
 1
H NMR (300 MHz, CDCl3):   0.89 (d, J = 6.5 
Hz, 3H); 0.91-1.13 (m, 3H); 1.12 (s, 3H); 1.14 (s, 3H); 
1.19-1.47 (m, 2H); 1.55 (d, J = 1.5 Hz, 3H); 1.56-1.75 (m, 
2H); 1.76 (s, 3H); 1.89 (m, 1H); 3.16 (m, 1H); 3.30 (s, 
3H); 3.36 (td, J1 = 10.4 Hz, J2 = 4.0 Hz, 1H); 3.45 (m, 1H); 
4.59 (s, 1H); 4.93 (d, J = 1.2 Hz, 1H); 5.15 (m, 1H, 
CHH=);  5.87 (d, J = 1.2 Hz, 1H). 
13
C NMR (75 MHz, 
CDCl3):  17.8 (CH3); 18.4 (CH3); 20.9 (CH3); 22.1 (CH3); 
24.8 (CH2); 26.4 (CH3); 31.1 (CH); 34.8 (CH2); 40.9 
(2CH2); 44.9 (CH); 51.9 (CH3); 55.5 (C); 75.6 (CH); 81.7 
(C); 87.4 (CH); 111.6 (CH2); 127.1 (CH); 139.2 (C); 145.9 
(C). IR (film): 3085, 1675, 810, 735, 645 cm
-1
. HRMS 
calcd for C20H34NO2 [M + H]
+
 320,2584, found 320.2587 
(3R,4aR,5aS,6R,12aS)-3,8,12,12-tetramethyl-6-(2-
methylallyl)-2,3,4,4a,5a,6,7,10,12,12a-decahydro-1H-
benzo[5,6][1,3]oxazino[3,2-a]azepin-6-ol (22c). This 
compound was obtained from 19c (1.0 g) and catalyst 5, 
and purified by flash chromatography (hexanes/ ethyl 
acetate 35:1). Yield: 0.66 g, 72%. Colorless oil. [α]D
25
= -
38.1 (c = 1.0, CH2Cl2).
 1
H NMR (400 MHz, CDCl3):  
0.84-0.93 (m, 2H); 0.92 (d, J = 6.5 Hz, 3H); 1.09 (m, 1H); 
1.14 (s, 3H); 1.16 (s, 3H); 1.38 (m, 1H); 1.43 (m,1H);1.51 
(m, 1H); 1.66 (m, 1H); 1.70 (s, 3H); 1.76 (m, 1H); 1.85 (s, 
3H); 2.14 (d, J = 13.5 Hz, 1H); 2.35 (d, J= 13.5 Hz, 1H); 
2.78-2.91 (m, 3H); 3.36 (td, J1 = 10.7 Hz, J2 = 3.9 Hz, 1H); 
3.62 (dd, J1 = 13.5 Hz, J2 = 6.4 Hz, 1H); 4.48 (s, 1H); 4.74 
(m, 1H); 4.89 (m, 1H);  5.64 (m, 1H). 
13
C NMR (75 MHz, 
CDCl3):  22.2 (2 CH3); 24.5 (CH3); 25.1 (CH2); 26.2 
(CH3); 28.6 (CH3); 31.4 (CH); 35.0 (CH2); 37.4 (CH2); 
39.2 (CH2); 41.1 (CH2); 45.8 (CH); 46.9 (CH2); 57.8 (C); 
70.7 (C); 76.7 (CH); 89.4 (CH); 114.4 (CH2); 124.6 (CH); 
139.5 (C); 143.3 (C).   IR (film): 3080, 1640, 740, 670 
cm
-1
. HRMS calcd for C21H36NO2 [M + H]
+
 334.2741, 
found 334.2741. 
(3R,4aR,5aS,6S,12aS)-3,8,12,12-tetramethyl-6-(2-
methylallyl)-2,3,4,4a,5a,6,7,10,12,12a-decahydro-1H-
benzo[5,6][1,3]oxazino[3,2-a]azepin-6-ol (23c). This 
compound was obtained from 19c (1.0 g) and catalyst 6, 
and purified by flash chromatography (hexanes/ ethyl 
acetate 35:1). Yield: 0.18 g, 20%. Colorless oil. [α]D
25
= -
55.2 (c = 1.0, CH2Cl2).
 1
H NMR (300 MHz, CDCl3):  
0.84-1.02 (m, 1H); 0.93 (d, J=6.4 Hz, 3H); 1.07 (m, 1H); 
1.16 (s, 3H); 1.16 (s, 3H); 1.30 (m, 1H);  1.48 (m, 1H); 
1.54 (m, 1H); 1.66 (m, 1H); 1.73 (s, 3H); 1.85 (s, 3H); 1.91 
(m, 1H); 2.23 (d, J = 15.5 Hz, 1H); 2.25 (d, J= 13.5 Hz, 
1H); 2.39 (d, J= 13.5 Hz, 1H); 2.50 (d, J= 15.5 Hz, 1H); 
2.98 (dd, J1 = 15.2 Hz, J2 = 7.5 Hz, 1H); 3.07 (s broad, 
1H); 3.49 (td, J1 = 10.5 Hz, J2 = 4.0 Hz, 1H); 3.54 (m, 1H); 
4.57 (s, 1H); 4.76 (d, J = 0.9 Hz, 1H); 4.87 (d, J = 0.9 Hz, 
1H);  5.50 (m, 1H). 
13
C NMR (75 MHz, CDCl3):  20.7 
(CH3); 22.2 (CH3); 24.8 (CH3); 25.0 (CH2); 26.1 (CH3); 
28.1 (CH3); 31.3 (CH); 34.9 (CH2); 39.1 (CH2); 40.6 
(CH2); 41.1 (CH2); 46.1 (CH); 47.3 (CH2); 57.3 (C); 70.4 
(C); 76.1 (CH); 89.2 (CH); 114.7 (CH2); 124.2 (CH); 136.1 
(C); 143.0 (C). IR (film): 3545, 3070, 1640, 740, 630 cm
-1
. 
HRMS calcd for C21H36NO2 [M + H]
+
 334.2741, found 
334.2743. 
(3R,4aR,5aS,6R,12aS)-6-methoxy-3,8,12,12-
tetramethyl-6-(2-methylallyl)-2,3,4,4a,5a,6,7,10,12,12a-
decahydro-1H-benzo[5,6][1,3]oxazino[3,2-a]azepine 
(24c). This compound was obtained from 20c (1.0 g) and 
catalyst 5, and purified by flash chromatography (hexanes/ 
ethyl acetate 30:1). Yield: 0.87 g, 94%. White solid. Mp 
59-61 ºC (from pentane) [α]D
25
= -38.9 (c = 1.0, CH2Cl2).
 
1
H NMR (300 MHz, CDCl3):  0.84-0.99 (m, 2H); 0.91 (d, 
J=6.5 Hz, 3H); 1.02 (m, 1H); 1.08 (s, 3H); 1.16 (s, 3H); 
1.31 (m, 1H); 1.43 (m, 1H); 1.54 (m, 1H); 1.68 (m, 1H); 
1.74 (s, 3H); 1.83 (s, 3H); 1.87 (m, 1H); 2.06 (d, J = 16.1 
Hz, 1H); 2.28 (d, J = 14.8 Hz, 1H); 2.42 (d, J = 14.8 Hz, 
1H); 2.56 (d, J = 16.1 Hz, 1H); 3.15 (dd, J1 = 15.6 Hz, J2 = 
5.6 Hz, 1H); 3.22 (s, 3H); 3.33 (td, J1 = 10.6 Hz, J2 = 4.0 
Hz, 1H); 3.40 (m, 1H); 4.43 (s, 1H); 4.81 (d, J = 0.9 Hz, 
1H); 4.86 d, J = 0.9 Hz, 1H);  5.49 (m, 1H). 
13
C NMR (75 
MHz, CDCl3):  17.7 (CH3); 21.9 (CH3); 24.0 (CH3); 24.8 
(CH2); 25.5 (CH3); 27.3 (CH3); 30.8 (CH); 34.6 (CH2); 
37.4 (CH2); 38.6 (CH2); 39.2 (CH2); 40.8 (CH2); 47.1 
(CH); 49.3 (CH3); 57.0 (C); 75.4 (CH); 80.6 (C); 88.9 
(CH); 113.6 (CH2); 124.6 (CH); 134.1 (C); 142.1 (C). IR 
(nujol dispersion): 3075, 1640, 1455, 890 cm
-1
. . HRMS 
calcd for C22H38NO2 [M + H]
+
 348.2897, found 348.2906. 
(3R,4aR,5aS,6S,12aS)-6-((tert-butyldimethylsilyl)oxy)-
3,8,12,12-tetramethyl-6-(2-methylallyl)-
2,3,4,4a,5a,6,7,10,12,12a-decahydro-1H-
benzo[5,6][1,3]oxazino[3,2-a]azepine (27c). This 
compound was obtained from 21c (0.6 g) and catalyst 6, 
and purified by flash chromatography (hexanes/ ethyl 
acetate 80:1). Yield: 0.48 g, 85%. Colorless oil [α]D
25
= -
81.5 (c = 1.0, CH2Cl2).
 1
H NMR (300 MHz, CDCl3):  0.07 
(s, 3H); 0.78 (s, 3H); 0.85 (s, 9H); 0.86-0.98 (m, 2H); 0.93 
(d, J = 6.6 Hz, 3H); 1.11 (m, 1H); 1.13 (s, 3H); 1.15 (s, 
3H); 1.35 (m, 1H); 1.42-1.52 (m, 2H); 1.61 (m, 1H);  1.71 
(s, 3H); 1.82 (s, 3H); 1.93-2.00 (m, 2H); 2.31 (d, J = 13.2 
Hz, 1H); 2.46 (d, J = 13.2 Hz, 1H); 2.76 (d, J = 14.8 Hz, 
1H); 2.93 (dd, J1 = 14.5 Hz, J2 = 8.2 Hz, 1H); 3.45 (td, J1 = 
10.6 Hz, J2 = 3.9 Hz, 1H); 3.69 (m, 1H); 4.71 (s, 1H); 4.82 
(m, 1H); 4.84 (m, 1H); 5.44 (m, 1H). 
13
C NMR (75 MHz, 
CDCl3):  -2.5 (CH3); -1.6 (CH3); 18.8 (C); 22.9 (CH3); 
22.4 (CH3); 25.2 (CH2 + CH3); 26.3 (3 CH3); 26.4 (CH3); 
28.7 (CH3); 31.4 (CH); 35.1 (CH2); 38.3 (CH2); 41.1 
(CH2); 42.2 (CH2); 45.4 (CH); 47.1 (CH2) 57.5 (C); 76.4 
(O); 77.8 (C); 88.6 (CH); 115.3 (CH2); 124.4 (CH); 136.9 
(C); 142.7 (C IR (film): 3075, 1640, 705, 620 cm
-1
 HRMS 
calcd for C27H50NO2Si [M + H]
+
 448.3605, found 
448.3600. 
(3R,4aR,5aS,6R,12aS)-6-methoxy-3,12,12-trimethyl-6-
vinyl-2,3,4,4a,5a,6,9,10,12,12a-decahydro-1H-
benzo[5,6][1,3]oxazino[3,2-a]azepine (24d). This 
compound was obtained from 20d (1.0 g) and catalyst 5, 
and purified by flash chromatography (hexanes/ ethyl 
acetate 25:1). Yield: 0.37 g, 40%. Colorless oil. [α]D
25
= -
75.2 (c = 1.0, CH2Cl2).
 1
H NMR (400 MHz, CDCl3):  
0.78-0.93 (m, 2H); 0.85 (d, J = 6.6 Hz, 3H); 1.03 (m, 1H); 
1.08 (m, 3H); 1.12 (s, 3H); 1.29 (m, 1H); 1.39 (m, 1H); 
1.55 (m, 1H); 1.62 (m, 1H); 1.85 (m, 1H); 2.13 (m, 1H); 
2.23 (m, 1H); 2.92 (ddd, 1H, J1 = 14.1 Hz, J2 = 7.4 Hz, J3 = 
4.2 Hz, 1H); 3.07 (m, 1H); 3.11 (s, 3H); 3.34 (td, J1 = 10.6 
Hz, J2 = 4.1 Hz); 4.51 (s, 1H); 5.20 (dd, J1 = 10.7 Hz, J2 = 
1.6 Hz, 1H); 5.22 (dd, J1 = 17.5 Hz, J2 = 1.6 Hz, 1H); 5.45 
(dt, 1H, J1 = 11.5 Hz, J2 = 1.6 Hz, 1H); 5.94 (m, 1H); 5.95 
(dd, J1 = 17.5 Hz, J2 = 10.7 Hz, 1H). 
13
C NMR (100 MHz, 
CDCl3):  18.4 (CH3); 22.2 (CH3); 27.2 (CH3); 31.3 (CH); 
32.3 (CH2); 34.9 (CH2); 38.3 (CH2); 41.2 (CH2); 48.0 
 16 
(CH); 50.3 (CH); 57.1 (C); 76.5 (CH); 81.2 (C); 92.3 (CH); 
114.6 (CH2); 140.4 (CH). IR (film): 3075,1740, 1455, 725 
cm
-1
. HRMS calcd for C19H32NO2 [M + H]
+
 306.2428, 
found 306.2428. 
(3R,4aR,5aS,6S,12aS)-6-methoxy-3,12,12-trimethyl-6-
vinyl-2,3,4,4a,5a,6,9,10,12,12a-decahydro-1H-
benzo[5,6][1,3]oxazino[3,2-a]azepine (25d). This 
compound was obtained from 20d (1.0 g) and catalyst 6, 
and purified by flash chromatography (hexanes/ ethyl 
acetate 25:1). Yield: 0.57 g, 62%. Colorless oil. [α]D
25
= -
92.8 (c = 1.5, CHCl3). 
1
H NMR (300 MHz, CDCl3):  
0.81-0.98 (m, 2H); 0.89 (d, J = 6.5 Hz, 3H); 1.09 (m, 1H);  
1.16 (s, 3H); 1.23 (s, 3H); 1.40-1.51 (m, 2H); 1.54 (m, 
1H); 1.66 (m, 1H); 2.00 (m, 1H); 2.02-2.26 (m, 2H); 2.93 
(ddd, J1 = 13.6 Hz, J2 = 7.5 Hz, J3 = 2.7 Hz, 1H); 3.19 (m, 
1H); 3.24(s, 3H); 3.54 (td, J1 = 10.5 Hz, J2 = 3.9 Hz, 1H); 
4.78 (s, 1H); 5.32 (dd, J1= 10.5 HZ, J2= 1.7 Hz, 1H); 5.35 
(dd, J1= 17.5 HZ, J2= 1.7 Hz, 1H); 5.66 (d, J = 11.3 Hz, 
1H); 5.82 (dd, J1 = 17.5 Hz, J2 = 10.5 Hz, 1H); 6.0 (dt, J1= 
11.3 HZ, J2= 5.5 Hz, 1H). 
13
C NMR (75 MHz, CDCl3):  
22.2 (CH3); 22.2 (CH3); 25.4 (CH2); 28.1 (CH3); 29.9 
(CH2); 31.3 (CH); 35.0 (CH2); 40.8 (CH2); 41.5 (CH2); 
46.9 (CH); 50.8 (CH3); 57.7 (C); 77.1 (O); 82.1 (C); 90.1 
(CH); 116.0 (CH2); 127.8 (CH); 132.4 (CH); 137.7 (CH). 
IR (film): 3080, 1660, 730 cm
-1
. .HRMS calcd for 
C19H32NO2 [M + H]
+
 306.2428, found 306.2431. 
(3R,4aR,5aS,6S,12aS)-6-((tert-butyldimethylsilyl)oxy)-
3,12,12-trimethyl-6-vinyl-2,3,4,4a,5a,6,9,10,12,12a-
decahydro-1H-benzo[5,6][1,3]oxazino[3,2-a]azepine 
(27d). This compound was obtained from 21d (0.70 g) and 
catalyst 6, and purified by flash chromatography (hexanes/ 
ethyl acetate 50:1). Yield: 0.62 g, 94%. White solid. Mp 
80-81 ºC (from hexane) [α]D
25
= -100.9 (c = 1.0, CH2Cl2).
 
1
H NMR (300 MHz, CDCl3):   0.08 (s, 3H); 0.16 (s, 3H); 
0.85-1.01 (m, 2H); 0.89 (s, 9H); 0.91 (d, J = 6.6 Hz, 3H); 
1.02 (m, 1H); 1.16 (s, 3H); 1.20 (s, 3H); 1.41-1.53 (m, 
2H); 1.59 (m, 1H); 1.70 (m, 1H); 1.92 (m, 1H); 2.14 (m, 
1H); 2.30 (m, 1H); 2.93 (ddd, J1 = 13.7 Hz, J2 = 8.3 Hz, J3 
= 1.9 Hz, 1H); 3.20 (ddd, J1 = 13.7 Hz, J2 = 9.1 Hz, J3= 1.6 
Hz, 1H); 3.46 (td, J1 = 10.6 Hz, J2 = 3.8 Hz, 1H); 4.54 (s, 
1H); 5.05 (dd, J1 = 10.5 Hz, J2 = 1.9 Hz, 1H); 5.42 (d, J= 
11.2 Hz, 1H); 5.43 (dd, J1 = 17.1 HZ, J2 = 1.9 Hz); 5.72 (dt, 
J1 = 11.2 Hz, J2 = 5.6 Hz, 1H); 6.12 (dd, J1 = 17.0 Hz, J2 = 
10.5 Hz, 1H). 
13
C NMR (75 MHz, CDCl3):  -2.9 (CH3); -
2.5 (CH3); 18.7 (C); 22.3 (CH3); 22.8 (CH3); 25.4 (CH2); 
26.0 (3 CH3); 28.5 (CH3); 30.0 (CH2); 31.4 (CH); 35.2 
(CH2); 41.3 (CH2); 41.7 (CH2); 46.8 (CH); 57.8 (C); 77.1 
(CH); 80.3 (C); 91.3 (CH); 112.6 (CH2); 128.9 (CH); 134.9 
(CH); 141.2 (CH). IR (nujol dispersion): 3080, 1640, 740, 
670 cm
-1
. HRMS calcd for C24H44NO2Si [M + H]
+
 
406.3136, found 406.3142 
(3R,4aR,5aS,6R,13aS,Z)-3,8,13,13-tetramethyl-6-(2-
methylallyl)-2,3,4,4a,5a,6,10,11,13,13a-decahydro-
1H,7H-benzo[5,6][1,3]oxazino[3,2-a]azocin-6-ol (22e) 
This compound was obtained from 19e (1.0 g) and catalyst 
6, and purified by flash chromatography (hexanes/ ethyl 
acetate 50:1). Yield: 0.46 g, 50%. Colorless oil [α]D
25
= -5.6 
(c = 1.0, CH2Cl2).
 1
H NMR (300 MHz, CDCl3):  0.85-
0.98 (m, 2H); 0.91 (d, J = 5.9 Hz, 3H); 1.06 (m, 1H); 1.13 
(s, 3H); 1.17 (s, 3H); 1.22-1.33 (m, 2H); 1.44 (m, 1H); 
1.57 (m, 1H); 1,67 (m, 1H); 1.77 (s, 3H); 1.87 (s, 3H); 2.05 
(m, 1H); 2.18 (d, J= 13.5 Hz, 1H); 2,24 (m, 1H); 2.42 (d, J 
= 14.5 Hz, 1H); 2.47 (d, J = 14.5 Hz, 1H); 2.61 (d, J = 13.5 
Hz, 1H); 2.82 (m, 1H); 3.21 (ddd, J1 = 16.1 Hz, J2 = 9.4 Hz, 
J3 = 2.1 Hz, 1H); 3.45 (td, J1 = 10.6 Hz, J2 = 3.9 Hz, 1H); 
4.41 (s, 1H); 4.77 (m, 1H); 4.85 (m, 1H);  5.54 (m, 1H). 
13
C NMR (75 MHz, CDCl3):  22.2 (2 CH3); 22.7 (CH3); 
25.0 (CH2); 26.7 (CH3); 28.9 (CH3); 31.4 (CH); 33.4 
(CH2); 35.1 (CH2); 39.1 (CH2); 40.9 (CH2); 41.4 (CH2); 
46.0 (CH); 49.8 (CH2) 57.7 (C); 75.6 (C); 76.9 (CH); 88.7 
(CH); 114.8 (CH2); 126.0 (CH); 133.6 (CH); 143.5 (C). IR 
(film): 3320 (broad), 3090, 1650, 705 cm
-1
. HRMS calcd 
for C22H38NO2 [M + H]
+
 348.2897, found 348.2899. 
(3R,4aR,5aS,6R,13aS,Z)-6-methoxy-3,8,13,13-
tetramethyl-6-(2-methylallyl)-
2,3,4,4a,5a,6,10,11,13,13a-decahydro-1H,7H-
benzo[5,6][1,3]oxazino[3,2-a]azocine (24e). This 
compound was obtained from 20e (1.0 g) and catalyst 6, 
and purified by flash chromatography (hexanes/ ethyl 
acetate 25:1). Yield: 0.82 g, 88%. Colorless oil [α]D
25
= -
27.7 (c = 1.0, CH2Cl2).
 1
H NMR (300 MHz, CDCl3):  
0.80-0.97 (m, 2H); 0.90 (d, J = 6.6 Hz, 3H); 1.01 (m, 1H); 
1.17 (s, 6H); 1.28 (m, 1H); 1.42 (m, 1H); 1.56 (m, 1H);  
1.67 (m, 1H);  1.78 (d, J= 1.5 Hz, 3H); 1.80 (m, 1H); 1.84 
(s, 3H); 2.03 (d, J = 16.1 Hz, 1H); 2.15-2.21 (m, 2H); 2.36 
(d, J = 15.1 Hz, 1H); 2.45 (d, J = 15.1 Hz, 1H); 2.87 (m, 
1H); 3.00 (dt, J1 = 16.3 Hz, J2 = 5.3 Hz, 1H); 3.21 (dt, J1 = 
16.3 Hz, J2 = 6.2 Hz, 1H); 3.27 (s, 3H); 3.37 (td, J1 = 10.6 
Hz, J2 = 3.9 Hz, 1H); 4.61 (s, 1H); 4.83 (m, 1H); 4.89 (m, 
1H); 5.40 (m, 1H). 
13
C NMR (75 MHz, CDCl3):  20.8 
(CH3); 22.3 (CH3); 24.0 (CH3); 25.1 (CH2); 27.1 (CH3); 
29.6 (CH3); 31.4 (CH); 32.8 (CH2); 35.1 (CH2); 37.5 
(CH2); 39.3 (CH2); 41.4 (CH2); 42.1 (CH2); 47.1 (CH); 50.5 
(CH3); 58.1 (C); 76.1 (CH); 81.1 (C); 86.9 (CH); 114.0 
(CH2); 124.8 (CH); 130.5 (C); 143.2 (C) IR (film): 3075, 
1640, 735, 630 cm
-1
. HRMS calcd for C23H40NO2 [M + H]
+
 
362.3054, found 362.3063. 
(3R,4aR,5aS,6S,13aS,Z)-6-methoxy-3,8,13,13-
tetramethyl-6-(2-methylallyl)-
2,3,4,4a,5a,6,10,11,13,13a-decahydro-1H,7H-
benzo[5,6][1,3]oxazino[3,2-a]azocine (25e). This 
compound was obtained from 20e (1.0 g) and catalyst 6, 
and purified by flash chromatography (hexanes/ ethyl 
acetate 25:1). Yield: 0.02 g, 2%. Colorless oil [α]D
25
= -28.4 
(c = 0.3, CH2Cl2).
 1
H NMR (300 MHz, CDCl3):  (m, 1H); 
0.82-0.97 (m, 2H); 0.90 (d, J = 6.5 Hz, 3H); 1.08 (m, 1H); 
1.12 (s, 3H); 1.14 (s, 3H); 1.27 (m,1H); 1.46 (m,1H); 1.54 
(m,1H); 1.66 (m, 1H);  1.77 (d, J = 1.5 Hz, 3H); 1.82 (s, 
3H); 1.88 (m, 1H); 2.05-2.15 (m, 2H); 2.30 (d, J = 15.0 Hz, 
1H); 2.37 (d, 1H, CHH-C=, J= 15.4 Hz); 2.52 (d, 1H, 
CHH-C=, J= 15.0 Hz); 2.58 (d, J = 15.4 Hz, 1H); 2.85 (dt, 
J1 = 15.9 Hz, J2 = 4.1 Hz, 1H); 3.31 (td, J1 = 10.5 Hz, J2 = 
3.9 Hz, 1H); 3.35 (s, 3H); 3.75 (ddd, J1 = 15.9 Hz, J2 = 
11.0 Hz, J3 = 10.5 Hz, 1H); 4.47 (s, 1H); 4.86 (s, 2H); 5.44 
(m, 1H). 
13
C NMR (75 MHz, CDCl3): 20.6 (CH3); 21.2 
(CH3); 24.4 (CH3); 25.1 (CH2); 26.4 (CH3); 29.6 (CH3); 
31.4 (CH); 32.9 (CH2); 35.1 (CH2); 38.9 (CH2); 39.8 
(CH2); 41.5 (CH2); 42.1 (CH2); 46.9 (CH); 51.0 (CH3); 57.4 
(C); 76.7 (CH); 81.1 (C); 88.5 (CH); 113.9 (CH2); 125.9 
(CH); 131.3 (C=; 143.3 (C). IR (film): 3069, 1636, 620 cm
-
1. 
HRMS calcd for C23H40NO2 [M + H]
+
 362.3054, found 
362.3057. 
General procedure for hydrogenation of compounds 7a, 
7f and 14. 
A mixture of the unsaturated oxazine (0.15 g) and 10 wt % 
palladium on carbon (15 mg) in ethanol (1 mL) was stirred 
at room temperature under H2 at atmospheric pressure until 
the reaction was complete (TLC, 16-24 h). The catalyst 
was separated by filtration over a pad of Celite, after which 
the solvent was eliminated on a rotavapor, and the residue 
was purified by flash chromatography on silica gel. 
(2S,4aS,7R,8aR)-2-((2R,4R)-2-isobutyl-4-
methyltetrahydro-2H-pyran-2-yl)-4,4,7-
trimethyloctahydro-2H-benzo[e][1,3]oxazine (9). This 
compound was obtained from 7f (0.15 g) and, and purified 
by flash chromatography (hexanes/ ethyl acetate 12:1). 
Yield: 55 mg, 46 %. White solid. Mp 65-67 ºC (from 
pentane). [α]D
25
= -15.5 (c = 0.5, CH2Cl2). 
1
H NMR (300 
MHz, CDCl3):  0.80-0.96 (m, 2H); 0.84 (d, J = 6.5 Hz, 
3H); 0.89 (d, J = 6.5 Hz, 3H,); 0.90 (d, J = 6.6 Hz, 3H); 
0.92 (d, J = 6.6 Hz, 3H); 0.98-1.13 (m, 2H); 1.00 (s, 3H); 
1.04 (s, 3H); 1.25 (m, 1H); 1.29 (m, 1H), 1.36-1.52 (m, 
4H); 1.59-1.69 (m, 2H); 1.71-1.80 (m, 2H); 1.94 (m, 1H); 
2.03 (m, 1H); 3.27 (td, J1 = 10.4 Hz, J2 = 4.0 Hz, 1H); 3.66 
(m, 1H); 3.91 (m, 1H); 4.39 (s, 1H). 
13
C NMR (75 MHz, 
CDCl3):  19.7 (CH3); 22.3 (CH3); 23.3 (CH3); 23.6(CH); 
24.8(CH3); 25.3 (CH3); 25.6(CH); 25.7 (CH2); 30.1 (CH3); 
31.4 (CH); 24.2 (CH2); 35.1 (CH2); 39.6 (CH2); 42.0 
(CH2); 46.2 (CH2); 50.8 (C); 52.2 (CH); 62.8 (CH2); 75.3 
 17 
(CH); 76.6 (C); 85.1 (CH).  HRMS calcd for C21H40NO2 
[M + H]
+
 338.3054, found 338.3056 
(2S,4aS,7R,8aR)-2-((R)-2-ethyltetrahydrofuran-2-yl)-
4,4,7-trimethyloctahydro-2H-benzo[e][1,3]oxazine (10). 
This compound was obtained from 7a (0.15g) and purified 
by flash chromatography (hexanes/ ethyl acetate 12:1). 
Yield: 61 mg, 53 %. Colorless oil. [α]D
25
= -8.4 (c = 0.5, 
CH2Cl2). 
1
H NMR (300 MHz, CDCl3):  0.76-1.24 (m, 
4H); 0.83 (t, J = 7.6 Hz, 3H); 0.88 (d, J = 6.5 Hz, 3H); 1.00 
(s, 3H); 1.03 (s, 3H); 1.42 (m, 1H); 1.50-1.68 (m, 5H); 
1.76 (m, 1H); 1.85 (m, 1H); 1.93 (m, 1H); 2.08 (m, 1H); 
3.29 (td, J1 = 10.4 Hz, J2 = 4.0 Hz, 1H); 3.74-3.90 (m, 2H); 
4.13 (s, 1H). 
13
C NMR (75 MHz, CDCl3):  8.5 (CH3); 
19.7 (CH3); 22.3 (CH3); 25.8 (CH2); 26.6 (CH2); 29.5 
(CH2); 29.9 (CH3); 30.8 (CH2); 31.4(CH); 35.1 (CH2); 41.8 
(CH2); 50.7 (C); 51.6 (CH); 69.2 (CH2); 75.1 (CH); 
85.6(CH); 86.3 (C). HRMS calcd for C17H32NO2 [M + H]
+
 
282.2428, found 282.2432. 
General method for the elimination of the chiral 
auxiliary in 7a and 7c-g. A mixture of the oxazine 7 (2 
mmol), ethanol (20 mL) and a 3% aqueous solution of HCl 
(20 mL) was heated at reflux until the reaction was 
finished (TLC and 
1
H-NMR were used to monitor the 
reaction for disappearance of starting material). The 
mixture was cooled to 0 ºC, the pH was ajusted to 7-8 by 
addition of a 15% solution of NaOH and NaBH4 (226 mg, 
6 mmol) was added. The mixture was further stirred for 3 h 
at 0 ºC. Then 40 mL of H2O was added and the mixture 
was stirred for 1 h at room temperature. The aqueous 
mixture was extracted with ethyl ether (4 x 20 mL). The 
combined organic layers were washed with brine, dried 
over MgSO4, concentrated by distillation at atmospheric 
pressure and the resulting residue was purified by flash 
chromatography on silica gel. 
(R)-(2-vinyl-2,5-dihydrofuran-2-yl)methanol (15a). This 
compound was obtained from 7a (0.9 g) and purified by 
flash chromatography (hexanes/ ethyl ether 15:1). Yield: 
0.22 g, 72%. Colorless oil. [α]D
25
= +325.0 (c = 0.5, 
CH2Cl2). 
1
H NMR (300 MHz, CDCl3):  1.88 (s broad, 
1H); 3.62 (m, 2H); 4.71-4.78 (m, 2H); 5.18 (dd, J1= 10.7 
Hz, J2= 1.5 Hz, 1H); 5.33 (dd, J1= 17.3 Hz, J2= 1.5 Hz, 
1H); 5.76 (m, 1H); 5.90 (dd, J1= 17.1 Hz, J2= 10.7 Hz, 
1H); 6.02 (m, 1H). 
13
C NMR (75 MHz, CDCl3):   67.1 
(CH2); 75.4 (CH2); 93.1 (C); 115.1 (CH2); 128.2 (CH); 
128.8 (CH); 137.6 ( CH). IR (film): 3245 (broad), 1640, 
1420, 815, 725 cm
-1
. HRMS calcd for C7H10NaO2 [M + 
Na]
+
 149.0573, found 149.0578. 
(R)-(3-methyl-2-(prop-1-en-2-yl)-2,5-dihydrofuran-2-
yl)metanol (15c). This compound was obtained from 7c 
(1.0 g) and purified by flash chromatography (hexanes/ 
ethyl ether 15:1). Yield: 0.27 g, 70%. Colorless oil. [α]D
25
= 
-136.5 (c = 0.6, CH2Cl2). 
1
H NMR (300 MHz, CDCl3):   
1.66 (m, 3H); 1.71 (m, 3H); 2.08 (s broad, 1H); 3.80 (m, 
2H); 4.64 (m, 2H); 4.80 (s, 1H); 4.93 (s, 1H); 5.68 (m, 1H). 
13
C NMR (75 MHz, CDCl3):  11.8 (CH3); 18.9 (CH3); 
64.2 (CH2); 75.0 (CH2); 95.2 (C); 111.1 (CH2); 122.7 
(CH); 136.6 (C); 145.3 (C). IR (film): 3450 (broad), 3090, 
1640, 900, 860, 780, 765, 680 cm
-1
. HRMS calcd for 
C9H14NaO2 [M + Na]
+
 177.0886, found 177.0887. 
(R)-(3,4-dimethyl-2-(prop-1-en-2-yl)-2,5-dihydrofuran-
2-yl)metanol (15d). This compound was obtained from 7d 
(0.8 g) and purified by flash chromatography (hexanes/ 
ethyl ether 15:1). Yield: 0.29 g, 88%. Colorless oil. [α]D
25
= 
-112.7 (c = 1.5, CH2Cl2). 
1
H NMR (300 MHz, CDCl3):  
1.53 (s, 3H); 1.67 (s, 3H); 1.69 (s, 3H); 2.02 (s broad, 1H); 
3.78 (m, 2H); 4.56 (m, 2H); 4.77 (s, 1H); 4.90 (s, 1H). 
13
C 
NMR (75 MHz, CDCl3):  9.2 (CH3); 10.2 (CH3); 19.0 
(CH3); 64.3 (CH2); 78.8 (CH2); 96.6 (C); 110.7 (CH2); 
127.8 (C); 130.0 (C); 145.3 (C). IR (film): 3440 (broad), 
3085, 1640, 900, 850, 680 cm
-1
. HRMS calcd for 
C10H16NaO2 [M + Na]
+
191.1043, found 191.1049. 
(R)-(2-allyl-3,6-dihydro-2H-pyran-2-yl)metanol (15e). 
This compound was obtained from 7e (0.75 g) and purified 
by flash chromatography (hexanes/ ethyl ether 15:1). 
Yield: 0.20 g, 68%. Colorless oil. [α]D
25
= +42.2 (c = 1.0, 
CH2Cl2). 
1
H NMR (300 MHz, CDCl3):  1.61 (m, 1H); 
2.14 (m, 1H); 2.28-2.49 (m, 3H); 3.52 (s, 2H); 4.12-4.25 
(m, 2H); 5.08-5.31 (m, 2H); 5.89-5.70 (m, 3H). 
113
C NMR 
(75 MHz, CDCl3):  28.4 (CH2); 37.8 (CH2); 60.8 (CH2); 
66.0 (CH2); 73.7 (C); 118.2 (CH2); 122.5 (CH); 124.8 
(CH); 133.3 (CH). IR (film): 3435 (broad), 1640, 1100, 
740, 655 cm
-1
. 
1
 HRMS calcd for C9H14NaO2 [M + Na]
+
 
177.0886, found 177.0884. 
(R)-(4-methyl-2-(2-methylallyl)-3,6-dihydro-2H-pyran-
2-yl)metanol (15f). This compound was obtained from 7f 
(0.8 g) and purified by flash chromatography (hexanes/ 
ethyl ether 15:1). Yield: 0.25 g, 73%. Colorless oil. [α]D
25
= 
+37.7 (c = 0.6, CH2Cl2). 
1
H NMR (300 MHz, CDCl3):  
1.71 (d, J = 1.2 Hz, 3H); 1.82 (s, 3H); 1.88-2.07 (m, 3H); 
2.29 (d, J = 13.6 Hz, 1H)-2.36 (d, J = 13.6 Hz, 1H); 3.55 
(m, 2H); 4.14-4.23 (m, 2H); 4.76 (m, 1H); 4.89 (m, 1H); 
5.41 (m, 1H). 
13
C NMR (75 MHz, CDCl3):  23.3 (CH3); 
24.4 (CH3); 33.7 (CH2); 41.5 (CH2); 61.1 (CH2); 66.1 
(CH2); 74.5 (C); 115.0 (CH2); 118.1 (CH); 130.1 (C); 
142.2 (C). IR (film): 3450 (broad), 3070, 1640, 890, 770 
cm
-1
. HRMS calcd for C11H18NaO2 [M + Na]
+
 205.1199, 
found 205.1204. 
(R)-(4,5-dimethyl-2-(2-methylallyl)-3,6-dihydro-2H-
pyran-2-yl)metanol (15g). This compound was obtained 
from 13 (0.65 g) and purified by flash chromatography 
(hexanes/ ethyl ether 15:1). Yield: 0.18 g, 63%. Colorless 
oil. [α]D
25
= +28.8 (c = 0.8, CH2Cl2). 
1
H NMR (300 MHz, 
CDCl3):  1.55 (s, 3H); 1.65 (m, 3H); 1.82 (m, 3H); 1.89-
2.08 (m, 3H); 2.26 (d, J = 13.6 Hz, 1H); -2.35 (d, J = 13.6 
Hz, 1 H); 3.47-3.51 (m, 2H); 4.97-4.99 (m, 2H); 4.76 (m, 
1H); 4.89 (m, 1H). 
13
C NMR (75 MHz, CDCl3):  13.7 
(CH3); 18.6 (CH3); 24.4 (CH3); 34.6 (CH2); 41.5 (CH2); 
64.8 (CH2); 65.9 (CH2); 74.9 (C); 114.9 (CH2); 121.9 (C); 
122.6 (C); 142.3 (C). IR (film): 3450 (broad), 3070, 1640, 
890 cm
-1
. HRMS calcd for C12H20NaO2 [M + Na]
+
 
219.1356, found 219.1353. 
(1R,2S,5R)-2-(2-((R,Z)-3-methoxy-5-methyl-3-(2-
methylallyl)-3,4,7,8-tetrahydroazocin-1(2H)-yl)propan-
2-yl)-5-methylcyclohexan-1-ol (28). To a suspension of 
LiAlH4 (0.30 g, 7.9 mmol) in anhydrous THF (20 mL) 
cooled to -10 ºC and under nitrogen atmosphere was added, 
in portions, dry AlCl3 (0 35 g, 2.6 mmol). The mixture was 
stirred for 15 min at -10ºC and a solution of 24e (0.75g, 2.1 
mmol) in dry THF (15 mL) was slowly added. The 
reaction mixture was stirred at room temperature until 
disappearance of the starting product (TLC) and then it 
was quenched by addition of 10 % aqueous solution of 
NaOH (1.5 mL). The resulting mixture was filtered, the 
solid was washed with hot ethyl acetate, and the organic 
layer was dried over anhydrous MgSO4. The solvent was 
eliminated under reduced pressure. The residue was 
purified by flash chromatography (hexanes/ ethyl acetate 
2:1). Yield: 0.69 g, 92% White solid. Mp 94-96 ºC (from 
pentane). [α]D
25
= -35.1(c = 1.5, CH2Cl2). 
1
H NMR (300 
MHz, CDCl3, 333K):   0.82-1.06 (m, 2H); 0.90 (d, J = 6.5 
Hz, 3H); 0.91 (s, 3H); 1.17 (s, 3H, CH3); 1.38 (m, 1H); 
1.52-1.81(m, 3H); 1.77 (s, 3H); 1.81 (s, 3H); 1.93 (m, 1H);  
2.02-2.19 (m, 2H); 2.2-2.48 (m, 5H); 3.20 (m, 1H); 3.23 (s, 
3H); 3.62 (td, J1 = 10.1 Hz, J2 = 3.9 Hz, 1H); 4.88 (m, 1H); 
4.95 (m, 1H); 5.52 (m, 1H); 7.50 (s broad, 1H). 
13
C NMR 
(75 MHz, CDCl3, 333K):  20.2 (CH3); 21.9 (2 CH3); 24.2 
(CH3); 25.5 (CH3); 26.6 (CH2); 28.5 (CH2); 31.0 (CH); 
35.3 (CH2); 37.9 (CH2); 40.4 (CH2); 44.7 (CH2); 48.1 (CH); 
48.7 (CH3); 51.8 (CH2); 55.3 (CH2); 63.4 (C); 72.3 (CH); 
80.6 (C); 113.9 (CH2); 124.5 (CH); 137.0 (C); 141.8 (C). 
IR (nujol dispersion): 3170 (broad); 3075, 1640, 740 cm
-1
.
 
HRMS calcd for C23H42NO2 [M + H]
+
 364.3210, found 
364.3218. 
General method for elimination of the chiral auxiliary 
in 25a, 24b, 22c, 24c, 25d and 24e.To a suspension of 
LiAlH4 (0.30 g, 7.9 mmol) in anhydrous THF (20 mL) 
cooled to -10 ºC and under nitrogen atmosphere was added, 
in portions, dry AlCl3 (0.35 g, 2.6 mmol). The mixture was 
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stirred for 15 min at -10ºC and a solution of the 
corresponding benzoxazine (2.0 mmol) in dry THF (15 
mL) was slowly added. The reaction mixture was stirred at 
at room temperature until disappearance of the starting 
product by TLC (for reduction of 24b it was necessary to 
heat to 60 ºC), and then it was quenched by addition of 
10 % aqueous solution of NaOH (1.5 mL). The resulting 
mixture was filtered, the solid was washed with hot ethyl 
acetate, and the organic layer was dried over anhydrous 
MgSO4. The solvent was eliminated under reduced 
pressure, the residue was redissolved in anhydrous CH2Cl2 
(30 mL), and PCC (1.8 g, 8.0 mmol) and 3 Å molecular 
sieves (4.0 g) was added to this solution. The mixture was 
stirred under nitrogen atmosphere until the oxidation was 
finished (TLC). The mixture was then treated with a 10 % 
aqueous solution of NaOH (50 mL) and extracted with 
CHCl3 (5 x 25 mL). The organic phase was washed with 
brine, dried over anhydrous MgSO4 and the solvent were 
removed under reduced pressure. The residue was 
redisolved in THF (30 mL) and MeOH (15 ml), an aqueous 
solution of KOH 2.5M (15 mL) was added and the mixture 
stirred at room temperature for 5-6 h. After elimination of 
the THF and MeOH under reduced pressure, the residue 
was acidified with a 1 M solution of HCl to pH 2 and 
extracted twice with Et2O (2 x 20 mL). The aqueous 
solution was neutralized to pH 12 with a 10% aqueous 
solution of NaOH and extracted with CHCl3 (4 x 20 mL). 
The organic layer was washed with brine, dried over 
MgSO4, and the solvent eliminated under vacuum and the 
residue was purified by flash chromatography. 
(R)-4-methyl-3-(prop-1-en-2-yl)-1,2,3,6-
tetrahydropyridin-3-ol (29). This compound was 
obtained from 24b (0.65 g) and purified by flash 
chromatography (CHCl3/ MeOH 15:1). Yield: 0.19 g, 60%. 
Colorless oil. [α]D
25
= -10.5 (c = 0.8, CH2Cl2). 
1
H NMR 
(300 MHz, CDCl3):  1.62 (d,  J = 0.8 Hz, 3H); 1.70 (s, 3H, 
CH3); 2.29 (d, J = 12.8 Hz, 1H); 2.96 (d,  J = 12.8 Hz, 1H); 
2.90-3.00 (m, 2H); 3.28-3.29 (m, 2H); 5.01 (m, 1H); 5.15 
(m, 1H);  5.64 (m, 1H). 
13
C NMR (75 MHz, CDCl3, 
333K):  17.3 (CH3); 18.9 (CH3); 45.1 (CH2); 54.1 (CH2); 
73.8 (C); 112.5 (CH2); 124.9 (CH); 135.8 (C); 145.8 (C). 
IR (film): 3030 (broad), 3025, 1640, 740 cm
-1
. HRMS 
calcd for C9H16NO [M + H]
+
 154.1226, found 154.1230. 
(R)-5-methyl-3-(2-methylallyl)-2,3,4,7-tetrahydro-1H-
azepin-3-ol (30). This compound was obtained from 22c 
(0.65 g) and purified by flash chromatography (CHCl3/ 
MeOH 12:1). Yield: 0.21 g, 60%. Colorless oil. [α]D
25
= -
75.8 (c = 0.8, CH2Cl2). 
1
H NMR (300 MHz, CDCl3, 
333K):  1.75 (s, 3H); 1.8 5(s, 3H); 2.2 (s, 2H); 2.23 (d, J 
= 15.1 Hz, 1H); 2.36 (d, J = 15.1 Hz, 1H); 2.67 (s broad, 
2H); 2.74 (d, J = 12.8 Hz, 1H); 2.98 (d, J1 = 12.8 Hz, 1H); 
3.21 (m, 1H); 3.32 (dd, J1 = 15.4 Hz, J2 = 7.0 Hz, 1H); 4.72 
(d, 1H, J = 0.8 Hz); 4.87 (s, 1H); 5.65 (m, 1H). 
13
C NMR 
(75 MHz, CDCl3, 333K):  24.5 (CH3); 27.5 (CH3); 45.7 
(CH2); 47.9 (CH2); 48.5 (CH2); 61.7 (CH2); 69.7 (C); 114.7 
(CH2); 124.8 (CH); 136.7 (C); 142.6 (C). IR (film): 3330 
(broad), 3070, 1645, 890 cm
-1
. HRMS calcd for C11H20NO 
[M + H]
+
 182.1539, found 182.1543. 
(R)-3-methoxy-5-methyl-3-(2-methylallyl)-2,3,4,7-
tetrahydro-1H-azepine (31). This compound was 
obtained from 24c (0.85 g) and purified by flash 
chromatography (CHCl3/ MeOH 15:1). Yield: 0.28 g, 59%. 
Colorless oil. [α]D
25
= +19.8 (c = 1.0, CH2Cl2). 
1
H NMR 
(400 MHz, CDCl3):  1.73 (s, 3H); 1.75(s, 3H);2.8 (1H); 
2.14 (d, J = 14.4 H<, 1H); 2.21 (d, J = 14.4 Hz, 1H); 2.27 
(d, J = 15.2 Hz, 1H); 2.40 (d, J = 15.2 Hz, 1H); 2.78 (d, J = 
14.5 Hz, 1H); 3.04 (d, J =15.5 Hz, 1H); 3.17 (m, 1H); 3.18 
(s, 3H); 3.32 (dd, J1 =16.1 Hz, J2 = 5.4 Hz, 1H), 4.70 (s, 
1H); 4.81 (s, 1H); 5.49 (m, 1H). 
13
C NMR (100 MHz, 
CDCl3):  24.0 (CH3); 27.0 (CH3); 41.0 (CH2); 42.3 (CH2); 
48.3 (CH2); 49.2 (CH3); 58.3 (CH2); 77.0 (C); 114.5 (CH2); 
126.3 (CH); 134.8 (C); 142.0 (C). IR (film): 3380 (broad), 
3075, 1645, 1460, 890 cm
-1
. HRMS calcd for C12H22NO 
[M + H]
+
 196.1696, found 196.1692. 
(R, Z)-3-methoxy-5-methyl-3-(2-methylallyl)-1,2,3,4,7,8-
hexahydroazocine (32). This compound was obtained 
from 24e (0.75 g) and purified by flash chromatography 
(CHCl3/ MeOH 20:1). Yield: 0.22 g, 52%. Colorless oil. 
[α]D
25
= -69.9 (c = 1.5, CH2Cl2). 
1
H NMR (300 MHz, 
CDCl3, 300K):  (s, 6H); 1.93-2.07 (m, 2H); 2.15 (d, J = 
14.8 Hz, 1H); 2.17 (m,1H); 2.21 (d, J = 13.4 Hz, 1H); 2.27 
(d, J =13.4 Hz, 1H); 2.28 (d, J = 14.8 Hz, 1Hz); 2.59, J = 
14.4 Hz, 1H); 2.61 (m, H); 3.22 (s, 3H); 4.76 (d, J = 0.8 Hz, 
1H); 4.83 (d, J = 0.8 Hz, 1H); 5.41 (m, 1H,). 
13
C NMR (75 
MHz, CDCl3, 300K):  24.0 (CH3); 26.3 (CH3); 29.6 
(CH2); 38.3 (CH2); 41.6 (CH2); 48.9 (CH3); 49.2 (CH2); 
53.3 (CH2); 82.1 (C); 114.2 (CH2); 123.8 (CH); 137.7 (C); 
142.3 (C). IR (film): 3370 (ancha); 3075, 1640, 690 cm
-1
. 
HRMS calcd for C13H24NO [M + H]
+
 210.1852, found 
210.1849. 
(S)-3-methoxy-3-vinyl-1,2,3,6-tetrahydropyridine (33). 
This compound was obtained from 25a (0.75 g) and 
purified by flash chromatography (CHCl3/ MeOH 15:1). 
Yield: 0.20 g, 56%. Colorless oil. [α]D
25
= +52.1(c = 0.5, 
CH2Cl2). 
1
H NMR (300 MHz, CDCl3):  2.30 (broad, 1H); 
2.69 (d, J = 13.2 Hz, 1H); 3.01 (d, J = 13.2 Hz, 1H); 3.21-
3.38 (m, 2H); 3.24 (s, 3H); 5.21 (d, J = 17.6 Hz, 1H), 5.27 
(d, J = 10.8 Hz, 1H); 5.80 (dd, J1 = 17.6 Hz, J2 = 10.8 Hz, 
1H); 5.99 (m 1H,) 6.06 (m, 1H). 
13
C NMR (75 MHz, 
CDCl3):  44.9 (CH2); 50.7 (CH3); 52.7 (CH2); 72.6 (C); 
116.9 (CH2); 126.3 (CH); 132.4 (CH);140.4 (CH). IR 
(film): 3320 (broad), 3085, 1635, 1460, 720, 685 cm
-1
. 
HRMS calcd for C8H14NO [M + H]
+
 140.1070, found 
140.1071 
(S)-3-methoxy-3-vinyl-2,3,6,7-tetrahydro-1H-azepine 
(34). This compound was obtained from 25d (0.65 g) and 
purified by flash chromatography (CHCl3/ MeOH 15:1). 
Yield: 0.22 g, 68%. Colorless oil. [α]D
25
= -4.2 (c = 1.2, 
CH2Cl2). 
1
H NMR (300 MHz, CDCl3):  2.28-2.35 (m, 
2H); 2.89-3.20 (m, 4H); 3.24 (s, 3H); 3.50 (broad, 1H); 
5.27-5.36 (m, 2H); 5.70 (m, 2H); 6.05 (m, 1H). 
13
C NMR 
(75 MHz, CDCl3):  30.7 (CH2); 47.8 (CH2); 50.9 (CH3); 
55.9 (CH2); 77.00 (C); 117.6 (CH2); 131.7 (CH); 133.1 
(CH); 140.2 (CH). IR (film): 3410 (broad); 3085, 1640, 
146, 755 cm
-1
. HRMS calcd for C9H16NO [M + H]
+
 
154.1226, found 154.1228. 
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